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Lipids play crucial roles in maintaining cellular structure and energy storage. Structural lipids in 
the form of phospholipids constitute almost 10% of the dry cell weight in bacteria with their 
synthesis requiring 32 moles of ATP per mole of lipid. This significant investment ensures that the 
flux through the fatty acid biosynthesis (FAS) and related metabolic pathways is very precisely 
coordinated. A key feature of the FAS pathway is the acyl carrier protein (ACP), which is a small 
acidic protein that tethers acyl intermediates via a high-energy thioester bond and shuttles them 
between enzymes. In Escherichia coli, ACP is one of the most abundant soluble proteins with 
about 60000 copies per cell. Despite being the subject of extensive biochemical and structural 
studies for several decades, a reliable snapshot of ACP-bound species in any organism under 
different conditions is unavailable. Previously used methods are severely limited in their capacity 
to differentiate fatty acid intermediates, suffer from poor reproducibility, require elaborate 
instrumentation and cannot be used in an ideal setting for determining intracellular fluxes.  
This dissertation describes a sensitive and facile method to identify and quantify the physiological 
level of acyl-ACP species in E. coli and Bacillus subtilis under varying conditions of growth. The 
method primarily relies on an inert strep-tagged ACP which is purified using a two-step 
purification strategy utilizing volatile buffers of low pH in order to preserve the thioester bond 
between the acyl group and ACP. Samples obtained via this method were extremely pure and free 





Short and medium chain saturated fatty acyl-ACPs as well as long chain saturated and unsaturated 
fatty acyl-ACP intermediates were observed. Apart from validating widely held ideas about acyl-
ACP flux in basic metabolism, acetyl-ACP, a novel intermediate, was also observed in abundance 
along with much lower levels of holo-ACP than previously thought. Current efforts are focusing 
on developing and validating a new model for the initiation of fatty acid biosynthesis using a 
combination of FAS mutants and stable-isotope labelling studies.  
 
During our efforts to construct one such mutant, we identified and characterized the function of a 
FabG temperature-sensitive mutant missing eight residues at its dimerization interface. 
Surprisingly, this mutant behaved like a point mutant. We identified interactions within the 
dimerization/tetramerization interface that compensate for each other and showed that the wildtype 
FabG predominantly exists as a dimer but functions as a tetramer. The mutation also rendered the 
enzyme extremely sensitive to calcium in vitro and conferred resistance to a calmodulin inhibitor 
in vivo.  
 
In B. subtilis, we have determined that the cellular levels of ACP are ten times lower than those in 
E. coli. when normalized to the total protein content per cell. Even under our stringent purification 
conditions, ACP co-purified with several other proteins, most noticeably FabF.  We are currently 
trying to identify if Bacillus ACP is part of a loose complex. Nevertheless, this method has also 
successfully resolved all expected fatty acid intermediates associated with ACP including the 




In addition, I also discuss the development of a new set of vectors with IPTG-dependent origins 
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Functional biological membranes are essential for living organisms. Membranes primarily serve a 
structural role in the form of selectively permeable barriers that control the movement of 
biomolecules. In bacteria and eukaryotes, the cell membrane is made up of phospholipids, the 
hydrophobic components of which are composed of fatty acids, while archaea have isoprenoid-
derived lipids. In addition to the cell membrane, Gram-negative bacteria contain an outer 
membrane, the outer leaflet of which is lipopolysaccharide which contain fatty acids as well.  
These lipid-rich membranes can also be directly involved in a number of cellular processes such 
as energy generation and storage, cell signaling, adhesion and pathogenesis. As a consequence, the 
homeostatic maintenance of the cellular membranes and growth require a constant source of fatty 
acids, the majority of which are synthesized de novo. Two predominant fatty acid biosynthetic 
systems (FAS) exist in nature: The type I or associated system, found in mammals1,2 in fungi3, 
which utilizes a large multifunctional enzyme complex (270 kDa to 2.6 MDa) containing all the 
activities necessary to synthesize new fatty acids on a single polypeptide chain, and the type II or 
dissociated system, in bacteria and plants, which has discrete enzymes performing the individual 
biosynthetic reactions and a small carrier protein (acyl carrier protein or ACP) that shuttles the 
intermediates between the enzymes.  Given this fundamental difference, the enzymes of bacterial 
FAS are of tremendous pharmaceutical interest. The model organism for studying type II FAS is 
Escherichia coli where the pathway has been characterized in significant detail. Despite this, 
several questions remain regarding the structural and mechanistic aspects of each of the individual 
enzymes and how they are regulated under different conditions. 
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1.1 TYPE II FATTY ACID BIOSYNTHETIC REACTIONS 
 
Type II fatty acid synthesis begins with the carboxylation of acetyl-CoA using free bicarbonate to 
generate malonyl-CoA. This is a ATP- and biotin-dependent reaction catalyzed by acetyl-CoA 
carboxylase and is the first committed step of fatty acid synthesis4.  The malonyl group is 
transferred from CoA to the thiol of ACP by a malonyl-CoA-ACP transacylase5 (FabD).  
 
During the initial round of FAS, the malonyl-ACP is condensed with acetyl-CoA to form 
acetoacetyl-ACP in a Claisen condensation reaction catalyzed by a β-ketoacyl-ACP synthase6 
(KASIII; FabH).  The β-keto group of acetoacetyl-ACP is then reduced to a hydroxyl group by the 
activity of a β-ketoacyl-ACP reductase FabG in a NADPH dependent manner7,8. The β-
hydroxybutyryl-ACP is then dehydrated by a β-hydroxyacyl-ACP dehydratase FabZ9 to form 
trans-2-butenoyl-ACP which is reduced to butyryl-ACP by a NADH dependent enoyl-ACP 
reductase FabI. While the previous reduction and dehydration reactions are reversible, the 
equilibrium of the FabI reaction lies strongly towards product formation and pulls the cycle 
forward. At the end of each cycle of FAS, the saturated fatty acyl-ACP is two carbons longer than 
when it entered the cycle and can renter the cycle via condensation to malonyl-CoA catalyzed by 
FabB (KASI) or FabF (KASII). This cycle continues till the desired chain length is reached10. 
FabH is predominant at shorter chain lengths (<6-8 carbons) while FabB/FabF catalyze 
condensations with longer acyl-ACPs.  
 
Though FabB and FabF have significant overlapping β-ketoacyl-ACP synthase activity, only FabF 
can elongate palmitoyl-ACP to cis-vaccenoyl-ACP, necessary for regulation of membrane fluidity 
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at varying temperatures. However, this activity and hence, FabF, are non-essential. Though more 
than 90% of FAS is initiated by FabH using acetyl-CoA, FabH itself is not strictly essential. This 
is possibly due to the remaining 10% of initiation proceeding using acetyl-ACP instead of acetyl-
CoA. The acetyl-ACP itself can be synthesized to a small extent by the transacylation of acetyl-
CoA by FabH. However, further studies are necessary to elucidate the proteins responsible for 
producing this acetyl-ACP and then condensing it with malonyl-ACP.  
 
FabB, however, is essential in E. coli due to its indispensable role in unsaturated fatty acid 
synthesis (UFA).  The branch point for UFA synthesis occurs when another dehydratase, FabA, 
specific for β-hydroxydecanoyl-ACP converts it to trans-2-decenoyl-ACP. FabA can also catalyze 
the isomerization of trans-2-decenoyl-ACP to cis-3-decenoyl-ACP. This cis double bond cannot 
be reduced by FabI and the cis-3-decenoyl-ACP synthesized is further elongated by exclusively 
FabB while retaining the double bond. Other organisms like Helicobacter pylori are shown to 
utilize a unique and distinct backtracking mechanism in UFA synthesis involving the 
dehydrogenation of decanoyl-ACP to trans-2-decenoyl-ACP and its subsequent isomerization to 
cis-3-decenoyl-ACP using the enzyme FabX11. 
 
Elongation of acyl-ACPs concludes when the desired acyl chain length is achieved. The fatty acid 
predominant in E. coli phospholipids are palmitic acid (C16:0), cis-vaccenic acid (C18:1), 
palmitoleic acid (C16:1) and to a smaller extent myristic acid (C14:0) and myristoleic acid 
(C14:1)12. The final length is, however, determined as a competition between condensation by β-
ketoacyl-ACP synthases and phospholipid synthesis. The acyltransferase PlsB transfers acyl 
groups from ACP to glycerol-3-phosphate to form lysophosphatidic acid and terminates fatty acid 
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synthesis. A second acyl chain is transferred by PlsC to form the primary precursor for 
glycerophospholipids (phosphotidylglycerol, phosphotidylethanolamine and cardiolipin in E. 
coli).  
 
In addition to phospholipid synthesis, shorter acyl-ACP intermediates are also siphoned off by 
enzymes from other synthetic processes. Malonyl-ACP is utilized by BioC, a malonyl-ACP 
methyltransferase during biotin synthesis to produce methyl malonyl-ACP. This masks the free 
carboxyl group and allows it to be extended as an odd carbon-length acyl-ACP intermediate by 
FAS till it reaches the necessary length (seven carbons) for subsequent biotin synthesis enzymes. 
The octonoate moiety of octonoyl-ACP is transferred by LipB during lipoic acid synthesis13 to the 
lipoyl domain of 2-oxoacid dehydrogenases. Acyl-ACPs that are 14-16 carbon long are utilized as 
substrates to acylate the protoxin form of hemolysin, via the action of the acyltransferase HlyC. 
Acyl groups from β-hydroxymyristoyl-ACP via LpxC, myristoyl-ACP via LpxM and lauroyl-ACP 
via LpxL are respectively utilized during Lipid A biosynthesis. Acyl-ACPs of different lengths are 
also used by acyl-homoserine lactone synthases to produce quorum sensing molecules. 
 
 In E. coli, acyl-ACPs are intermediates dedicated to the biosynthetic pathway while acyl-CoAs 
(except acetyl-CoA) are part of the catabolic β-oxidation pathway. Hence, certain enzymes that 
specifically require acyl-ACPs like those in lipid A synthesis cannot be supplemented with 
exogenous fatty acids while those in phospholipid synthesis like PlsB/C which can utilize either 
acyl-ACPs or acyl-CoAs can. This makes fatty acid biosynthesis absolutely essential in an 




1.2 THE ACYL CARRIER PROTEIN 
 
The acyl carrier protein is a common feature of both type I and type II fatty acid biosynthesis. In 
the type I system, it exists as a domain of the large polypeptide complex, while in the type II system 
it is found as a discrete protein that is covalently bound to all acyl intermediates until they are 
finally transferred to their final recipients.  Analogous proteins called PKS ACPs and PCPs are 
also found in polyketide synthesis and non-ribosomal polypeptide synthesis, respectively, and 
perform a very similar function14.  
 
The ACP of E. coli is a small acidic protein with a molecular mass of 8.86 kDa and a low isoelectric 
point of 4.1. This protein is extremely soluble and can be routinely resolubilized in an active form 
even after harsh protein precipitation/denaturation treatments. Most type II ACPs are strongly 
conserved and contain four alpha helices. Helix I is antiparallel to helix II and helix IV, which are 
parallel to each other and linked via the very short Helix III which is perpendicular to both helices. 
A specific conserved serine (Ser 36 in E. coli) present on helix II is modified post-translationally 
with a 4’-phosphopantetheine moiety (4’-PP) through a phosphodiester bond. This 4’-PP moiety 
contains a terminal thiol to which the acyl intermediates are covalently attached as a thioester. In 
E. coli a specific and essential holo-ACP synthase AcpS attaches the 4’-phosphopantetheine group 
derived from coenzyme A to its apo-ACP substrate15.   
 
This four-helix bundle is flexible and dynamic in solution. This is seen in high-resolution X-ray 
crystallographic data of apo, holo and acylated forms of various ACPs along with solution state 
NMR analyses. These crystal structures have revealed that Helix I, II and IV are amphipathic and 
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have very hydrophobic inner faces and very acidic outer faces and form a hydrophobic sleeve 
between helix II and helix IV that can sequester the acyl chain and protect it from the solvent16.  
In fact, simply having the 4’-PP group offers a degree of stability as evidenced by reduction in the 
hydrodynamic radius of holo-ACP in comparison to apo-ACP. The degree of stabilization of the 
ACP structure is seen to increase with acyl chains up to eight carbons in length suggesting 
increased interactions with the hydrophobic pocket and indirectly providing a rough physical 
estimation of the size of the hydrophobic pocket itself. Accommodation of longer acyl chain length 
is explained by an expanding hydrophobic pocket that pushes helix I away. This, however, comes 
at the cost of thioester bond stability because longer chains can increase solvent access to the 
thioester bond. Helix III itself has been seen in a multitude of conformations, and its proximity to 
the thioester bond suggests that its movements might be critical to accessing proximal parts of the 
acyl chain. 
 
Co-crystals of ACP with interacting enzymes like AcpS, FabA, LpxD, BioI and BioC suggest that 
hydrophilic interactions between specific parts of ACP and an arginine/lysine rich ‘positive patch’ 
on the interacting enzyme mediate recognition between the proteins. Salt bridges from the acidic 
residues of helix II of ACP are thought to be primarily involved in this interaction.  However, 
similar salt bridges have also been observed from helix I and IV in other instances. These structures 
also suggest that to access the acyl chains very little structural change is required, and a transient 
destabilization of the amphipathic helices of ACP is sufficient to partition the acyl chains into the 
active sites of the cognate protein. This ‘chain flipping’ mechanism is spontaneous, and the 
location of the acyl chain is most likely determined by the relative protection offered by the 
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hydrophobic pockets of either ACP or its cognate enzyme. This mechanism would probably also 
extend to PKS ACPs and PCPs since they retain a similar helical bundle fold.   
 
1.3 INTRACELLULAR TURNOVER OF ACP PROSTHETIC GROUP 
 
ACP itself is one of the most abundant monomeric proteins in E. coli. More than 60,000 molecules 
of ACP exist per cell, constituting more than 0.25% of the total soluble protein. The only other 
proteins present in this scale understandably belong to the translation machinery.  
 
The 4’-phosphopantetheine group of ACP is known to undergo metabolic turnover independent of 
the protein. This was first shown by selectively incorporating radiolabeled 4’-phosphopantetheine 
in the intracellular ACP and CoA pools in pantothenate auxotrophs. In E. coli, the major enzyme 
that catalyzes the attachment of the prosthetic group is AcpS. This is a dimeric 4’-
phosphopantetheine transferase that transfers the 4’-phosphopantetheine group from coenzyme A 
to apo-ACP. E. coli AcpS is generally specific to its substrates and does not function with the 
structurally related polyketide and non-ribosomal polypeptide synthesis. Also, AcpS can utilize 
acetyl-ACP instead of ACP and butyryl-, acetoacetyl- and malonyl-CoAs instead of CoA. 
However, its low levels in E. coli suggest that this activity might not physiologically replace an 
enzyme like FabD in fatty acid synthesis. 
 
Another enzyme, AcpH, removes the 4’-phosphopantethiene moiety of ACP. Though AcpH is 
non-essential in E. coli, deletion of this gene leads to metabolic instability of the prosthetic group. 
The exact physiological role of AcpH remains unknown. Thomas and Cronan showed that the 
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amount of AcpH present in the cell can turn over the entire ACP pool in less than one minute. 4’-
phosphopantetheine is found to be excreted by exponential and stationary phase cells in an 
irreversible process with most of it derived from ACP turnover and very little from CoA turnover.  
 
1.4 COMPOSITION AND REGULATION OF THE INTRACELLULAR ACP POOL 
 
The composition of the intracellular pool of apo-, holo- and acyl-ACPs and the changes in the 
relative amounts of each of these species under different scenarios of fatty acid regulation has been 
the subject of some study. Given that fatty acid synthesis is an essential but energy intensive 
process with roughly 1 ATP and 1 NADPH required per two carbon extension, multiple levels of 
redundancy and regulation are expected to ensure that growth and cellular processes can proceed 
in an uninterrupted manner. 
  
A pool of apo-ACP might be expected either as an intermediate of holo-ACP synthesis or as a 
consequence of turnover of the 4’-phosphopantethiene group discussed before.  However, multiple 
lines of evidence have failed to demonstrate any significant apo-ACP pool under physiological 
conditions. Given that the intracellular concentration of CoA is roughly 8-10 times more than that 
of ACP, this is not surprising. Surprisingly, CoA starvation leads to a reduction in active ACP 
pools rather than an increase in apo-ACP.  This was later demonstrated to be a function of amino 
acid shortage caused by CoA starvation of the TCA cycle resulting in lower acpP transcription. 
Though overexpression of apo-ACP is toxic in E. coli, this has been shown to be due to PlsB 




Acyl-ACPs were first thought to represent more than 20% of the total intracellular ACP pool in E. 
coli. This was based on the fact that this pool was resistant to alkylation unless first treated with 
neutral hydroxylamine. Later work showed that this was closer to 12% in rapidly growing cells. 
Any significant accumulation of acyl-ACPs in the cell has also shown to inhibit fatty acid 
synthesis. Several fatty acid enzymes have also demonstrated inhibition by long-chain acyl-ACPs 
including acetyl-CoA carboxylase, the enoyl reductase FabI and the β-ketoacyl-ACP synthase 
FabH. This inhibition can also be triggered by blocking phospholipid synthesis and can be relieved 
by overexpressing thioesterases.  
 
Understanding the composition of the ACP pool could give clues towards rate-limiting steps or 
regulatory points in membrane lipid biogenesis. This regulation can happen either during the early 
stages of fatty acid biogenesis, by prosthetic group turnover as discussed before or at the point at 
which fatty acid biosynthesis feeds into phospholipid biosynthesis. Each of these scenarios 
suggests a completely different ACP pool. If early stages of fatty acid biogenesis are rate limiting, 
an increased accumulation of acetyl-ACP or malonyl-ACP or even holo-ACP would be expected. 
With the later stages, an accumulation of long chain acyl-ACPs are expected.  
Since the acyltransferase of phospholipid synthesis does not select from a large heterogenous pool 
of acyl-ACP species, it is unlikely that it decides the fatty acid composition. Instead, the 
modulation of fatty acid composition observed in various mutants of fatty acid biosynthesis argues 






1.5 THE INTERACTIVE NATURE OF ACP 
 
The acyl carrier protein undoubtedly plays a crucial role in fatty acid biogenesis, and its essentiality 
and intimate interaction with every member of this pathway has been shown in multiple ways 
including enzymatically and through structural data.  Given the cellular abundance of ACP and the 
relatively low amount of its acylated form in the cell, it has been frequently speculated that ACP 
might play a secondary role in the cell.  
 
In addition to its demonstrated role in fatty acid associated and dependent processes like biotin and 
lipoic acid production, lipid A synthesis and phospholipid synthesis, ACP has also been shown to 
interact with SpoT and mediate guanosine tetraphosphate (ppGpp) levels 17. ACP has also been 
shown to associate with membrane associated proteins like YchM 18 to mediate the acquisition of 
fatty acid precursors. While a lot is known about chain length specificities in specific pathways, a 
large number of basic questions regarding bacterial metabolism still remain. For example, even 
though the octanoyltransferase LipB has been characterized to specifically accept eight carbon 
length acyl-ACPs, the mechanisms guiding their scavenging activity is just being understood. 
 
Mechanism-based inhibitors like electrostatic cross linkers have been used in the past to treat E. 
coli cellular lysates and capture ACP-containing protein complexes. Similar phosphopantetheine 
based probes have also been employed in vivo by hijacking the CoA biosynthetic machinery. In 
fact, ACP could be identified using cycloaddition-based click chemistry or iterative mass 




Newer studies aimed at finding novel ACP interacting partners have largely used an affinity-based 
approach with the Tandem Affinity Purification (TAP) method being most popular. This requires 
co-purification of ACP and its interacting partner with little to no control over the ACP form used 
to bait the specific partners. Since a majority of the methods rely on the overexpression of the 
holo-form of ACP (via the co-expression of acpP and acpS), it is conceivable that a number of 
partners that require specific acylation of the ACP are missed. Regardless, in a large scale 
interactome study undertaken in E. coli 19, ACP was found to interact with GlmU (lipid A 
synthesis), AidB (isovaleryl-CoA dehydrogenase), SecA (pre-protein translocase) and MukB 
(chromosomal partitioning) in addition to the partners indicated before.  The physiological 
importance of these interactions is unclear. 
 
1.6 FATTY ACID SYNTHESIS INITIATION AND ITS INHIBITORS 
 
Initiation of fatty acid synthesis begins with the condensation of malonyl-ACP with acetyl-CoA 
by the activity of a β-ketoacyl-ACP synthase. Most of the initiation (90%) in E. coli proceeds 
through the activity of FabH, which utilizes acetyl-CoA. Given that FabH shares a similar 
structural fold with FabB and FabF, it could be hypothesized that one of the three enzymes could 
condense acetyl-ACP with malonyl-ACP. While FabB and FabF contain a His-His-Cys active site 
triad and an extended hydrophobic tunnel, structurally FabH only has a small pocket sufficient to 
bind acetyl-CoA along with a His-Asn-Cys active site. The active site itself is divided into two 
parts in all three enzymes: one-part binds malonyl-ACP and the other is used for forming an acyl-
enzyme intermediate. Two fungal compounds, cerulenin and thiolactomycin, can bind within the 




Cerulenin forms a covalent attachment with the active site cysteine of FabB and FabF in an 
irreversible manner. FabH is refractory to cerulenin, probably due to the lack of a hydrophobic 
tunnel of suitable size. Thiolactomycin, on the other hand, reversibly inhibits only type II FAS 
with all three enzymes being sensitive to this compound. Thiolactomycin acts by competing with 
malonyl-ACP binding. Overexpression of FabB makes E. coli resistant to thiolactomycin, 
indicating that FabB activity can bypass the other initiation pathways.   
 
The model Gram-positive organism Bacillus subtilis contains mostly iso and anteiso branched 
chain fatty acids of 14-17 carbon length in its phospholipids. They utilize acyl-CoA esters of 
isovalerate, isobutyrate and 2-methylbutyrate as primers instead of acetyl-CoA. These are derived 
from valine, leucine and isoleucine amino acid catabolic pathways utilizing a specialized 
branched-chain-keto-acid dehydrogenase complex. B. subtilis has two FabH homologs that can 
accept branch chain primers and initiate fatty acid synthesis. These can also utilize acetyl-CoA to 
a smaller extent. Thiolactomycin is shown to have very little effect on the branched chain synthases 
of Bacillus subtilis while cerulenin is shown to inhibit B. subtilis FabF.  
 
1.7 BETA-KETOACYL-ACP REDUCTASE: FABG 
 
β-ketoacyl-ACP reductases catalyze the reversible reduction of β-ketoacyl-ACP into β-
hydroxyacyl-ACP in a cofactor dependent manner and are members of the short-chain 
dehydrogenase/reductase (SDR) family. In E. coli, this activity is encoded by fabG, an essential 
NADPH dependent protein. fabG is present within the fatty acid biosynthetic cluster and is co-
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transcribed with plsX, fabH, fabD and acpP. FabG shows a preference for acyl-ACPs over acyl-
CoAs but is nonspecific for the carbon length of the acyl chain. FabG also functions with a variety 
of substrates including saturated and unsaturated fatty acid intermediates, methylated 
intermediates in biotin synthesis and even fluorescent molecules.  
 
FabG is easily overexpressed and purified in E. coli with very little toxicity. X-ray crystal 
structures of FabG from E. coli with NADPH have been determined at 2.05 A resolution. E. coli 
FabG contains a typical Rossmann fold structure with a twisted parallel beta sheet composed of 
seven beta strands flanked on both sides by eight alpha helices. The native structure of FabG is 
identified to be a dimer of dimers. Each monomer is bound to a molecule of NADP+ and two 
calcium atoms. It has been shown that NADPH binding is accompanied with conformational 
changes that organizes the active site residues Ser138, Tyr151 and Lys155, indicating allostery. 
 
The first temperature sensitive (Ts) mutants of fabG were isolated and characterized to be near the 
subunit interfaces of the FabG homotetramer. These mutant proteins were extremely thermolabile 
and could not be purified to homogeneity. Thus, it was hypothesized but never confirmed that 
these mutants were deficient in tetramerization in a temperature dependent manner. FabG(Ts) 
mutants accumulated butyryl-ACP and produced very little long chain acyl-ACP intermediates. 
Members of the SDR family show a strong conservation of structure despite having very low 
sequence homology. In fact, the conserved SDR folding pattern allows sequence specific 
assignment of the cofactor binding motif and the active site.  FabG is also closely related to another 
reductase in fatty acid synthesis, the enoyl-ACP reductase, FabI. FabI is primarily NADH 
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dependent. The equilibrium of the FabI reaction lies strongly towards reduced product formation 
and thus pulls the FabG reaction to completion in the context of fatty acid synthesis. 
 
One of the intermediate products of fatty acid synthesis from FabG, β-hydroxymyristoyl-ACP, is 
utilized in one of the first few steps of lipid A synthesis. The enzyme, LpxC, competes with FabZ 
for the β-hydroxymyristoyl-ACP produced by FabG, indirectly acting as a point of regulation 
between fatty acid and lipid A synthesis. In fact, the essentiality of lipid A synthesis has made it 
the target of several antimicrobial compounds. However, surprisingly only FabZ mutants with 
lower activity have been identified upon treatment of E. coli with these compounds. 
  
FabG itself is also of significant interest as an antimicrobial drug target since FabG homologs have 
been identified in every bacterial genome sequenced to date. Compounds targeting FabG would 
have a very broad range. However, no inhibitors of FabG have been reported so far. The biggest 
limitation is the functional flexibility of the FabG active site which makes it difficult to model 
inhibitors in a flexible binding pocket.  
 
1.8 AIMS AND SCOPE OF THIS THESIS 
 
Lipids are essential components of all living organisms. Synthesis of these lipids is an energy 
intensive process that is tightly regulated to meet the current physiological demand. Since lipids 
make up critical structural components of the cell, lipid biosynthesis is also flexible in the range 
of products it needs to produce to maintain membrane homeostasis. In bacteria, lipids are fatty 
acid derivatives and are synthesized by the type II fatty acid synthetic system. A number of 
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intermediates of this pathway are, however, required to sustain other critical biosynthetic pathways 
like biotin and lipoic acid synthesis, lipid A synthesis and quorum sensing.  This ensures that a 
very complex system of regulation exists to careful channel metabolic flux in a systematic manner. 
Though we have made great strides in understanding this regulatory mechanism in specific 
scenarios, a broad and holistic metabolic model is yet to be developed.  
 
Chapter 2 of this thesis describes a method developed to isolate and identify the intermediates of 
fatty acid biosynthesis in a facile and unbiased manner from Escherichia coli and Bacillus subtilis. 
This method relies on the fact that all fatty acid intermediates are naturally covalently tethered to 
the acyl carrier protein via a thioester linkage. A snapshot of the acyl-ACP pool of both organisms 
has been obtained under varying metabolic conditions. Acetyl-ACP is identified to be the 
predominant species of acyl-ACP in both organisms. As a consequence, the interactome of B. 
subtilis ACP has been characterized and its abundance relative to E. coli is shown to be 5-fold 
lower. 
 
Chapter 3 investigates the critical role of dimerization and tetramerization in E. coli FabG through 
the characterization of a temperature sensitive (Ts) version of FabG. This FabG mutant is unique 
in that the temperature sensitivity is caused due to an eight amino acid deletion unlike other Ts 
point mutants. The predominant form of E. coli FabG is now correctly attributed to its dimer state 
with tetramerization required before activity. This mutant was re-created in a clean background 




Chapter 4 describes a number of novel vector systems and tools developed to facilitate studies in 
Chapter 1 and 2. This includes a convenient and robust CRISPR-Cas9 toolkit that has also been 
developed based on the above vector backbone. Unlike existing CRISPR-Cas9 systems, these can 
be easily constructed, tightly regulated and rapidly cured in a reliable manner. To build the system 
a set of cloning vectors with IPTG dependent origins of replication from multiple incompatibility 
groups were constructed. These are shown to be maintained in different copy numbers in the 
presence of IPTG and rapidly lost when IPTG is withdrawn.  
 
Chapter 5 summarizes the results from the preceding chapters and discusses conclusions made 








Figure 1.1 The fatty acid biosynthetic reactions. The canonical initiation and elongation steps 
of fatty acid biosynthesis are represented. The carboxyl group of malonyl-CoA is depicted in green 
while the acetyl group is in orange to illustrate the head to tail condensation that initiates fatty acid 
synthesis. The fatty acid synthetic enzymes of E. coli are FabB, FabH and FabF: β-ketoacyl-ACP 
synthase; FabG: β-ketoacyl-ACP reductase; FabZ: β-hydroxyacyl-ACP dehydratase; FabI: enoyl-
ACP reductase; ACP: Acyl carrier protein. 
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Figure 1.2 Ribbon representation of the structure of decanoyl-ACP. X-ray crystal structure of 
E. coli ACP (PDB 2FAE) with its characteristic four helix bundle. The conserved serine residue 
(Ser36) is indicated on Helix 2 (in green). This is attached to a 4’-phosphopatetheine via a 
phosphodiester bond. The decanoyl thioester is sequestered with the hydrophobic cavity formed 











Figure 1.3 Model of the initiation step of fatty acid synthesis. More than 90% of flux to 
acetoacetyl-ACP is through FabH, which condenses acetyl-CoA with malonyl-ACP. Malonyl-
ACP is synthesized by first carboxylating acetyl-CoA using the enzyme acetyl-CoA carboxylase 
(ACC). This malonyl group is transferred to ACP using the malonyl-CoA-ACP acyltransferase 
FabD. This is indicated by solid lines. However, the remaining 10% is thought to involve acetyl-
ACP which might be produced by decarboxylating malonyl-ACP or by transacylating an acetyl 











Figure 1.4 Interactome of E. coli ACP. A spoke diagram depicting the E. coli proteins that are 
known to interact with ACP as identified by tandem affinity purification. Of these FabD, FabH, 
Fab Z, FabG, FabA, FabI, FabF and FabB are fatty acid biosynthetic genes and AcpS and AcpH 
are involved in 4’-phosphopantetheine turn over.  ACP seems to interact with proteins in other 







































Figure 1.5 Ribbon representation of E. coli FabG in its tetrameric and monomeric forms.   
The FabG monomer contains a typical Rossmann-fold structure with a twisted parallel beta sheet 
composed of seven beta strands flanked on both sides by eight alpha helices. Though no data exists 
about the native oligomerization state of E. coli FabG, it is known to function as a tetramer (dimer 








IDENTIFICATION AND CHARACTERIZATION OF FATTY ACID 





As described in Chapter I, ACP is the central player in bacterial fatty acid synthesis. Each fatty 
acid biosynthetic intermediate is covalently attached to an ACP molecule via a thioester bond to 
the thiol in its prosthetic group, 4’-phosphopantetheine. The prosthetic group comes from the non-
nucleotide portion of CoA, and its attachment to ACP is catalyzed by a holo-ACP synthase, AcpS 
15. The prosthetic group may also be cleaved by the action of a phosphodiesterase, AcpH 20.  
However, this turnover is independent of fatty acid synthesis where holo-ACP is released only 
when its acyl group gets transferred to complex lipids. This happens once the acyl group reaches 
a chain length desired by its target enzymes.  
 
The major destination for long chain fatty acids in the cell is in the structural phospholipids of the 
cellular membranes. Thus, a bulk of the studies of bacterial fatty acid synthesis have proceeded by 
analyzing the fatty acid composition of the phospholipids. This was further facilitated by simple 
and convenient methods of organic extraction like that by Bligh and Dyer 21 and by fast separation 
techniques like thin-layer, liquid and gas chromatography. However, it is now clear that fatty acid 
synthesis acts as a feeder pathway for several other essential pathways in bacteria. In E. coli, where 
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this is best studied, biotin and lipoic acid synthesis, lipid A synthesis and quorum sensing amongst 
others directly depend on shorter acyl-ACP intermediates of fatty acid biosynthesis. In fact, several 
of the enzymes 13,22,23 in these pathways require the acyl groups to be specifically bound to ACP 
and not CoA or be in their free-acid form. Further, from several protein interactome studies 19,24,25 
undertaken in E. coli, it is clear that ACP interacts with enzymes in a variety of processes such as 
stringent response and protein translocation amongst others that have no obvious co-relation with 
fatty acid synthesis. A comprehensive understanding of the metabolic flow of acyl species in the 
cell is unavailable.  
 
In Bacillus subtilis, a model organism for Gram-positive bacteria, even less information is 
available about fatty acid synthesis and its interplay with other dependent pathways. Though the 
individual enzymes in fatty acid synthesis have been characterized and are akin to those in E. coli, 
B. subtilis synthesizes very little saturated and unsaturated fatty acid and instead uses branched-
chain fatty acids in its phospholipids. The B. subtilis enzymes, thus, have differing configurations 
to accommodate the branched methyl and methylene groups. Further, while Gram-positive 
organisms lack an outer membrane and hence lipid A, their other fatty acid synthesis-dependent 
pathways like biotin and lipoic acid synthesis utilize straight-chain intermediates 26. Interestingly, 
certain Gram-positive organisms like Streptococcus pneumoniae and Enterococcus faecalis can 
survive at least partially on exogenous fatty acids, and exogenous fatty acid suppress de novo fatty 
acid synthesis. No conclusive evidence is available regarding whether these exogenous fatty acids 
are incorporated into their phospholipids as ACP thioesters or otherwise. A snapshot of the acyl 
species under various physiological conditions is necessary to get a holistic view of these bacteria. 
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This chapter focuses upon the development of methods that can reliably and quickly isolate acyl-
ACP species in a highly purified manner that is amenable to an unbiased mass spectrometric 
detection analysis. Determination of acyl-ACP species has been the subject of study for several 
decades. Most methods exploit the fact that all synthesized acyl intermediates are covalently linked 
to ACP by a thioester bond and can be detected as a modification on the ACP. Conveniently, E. 
coli ACP is one of the most abundant monomeric proteins, comprising more than 0.25% of total 
proteins and accounting to roughly 60,000 molecules per cell. This is unsurprising since, 
functionally, ACP is a cofactor and not an enzyme. Further, certain unique properties of ACP like 
its small size (8.8 kDa), unusually low isoelectric point (4.1) and flexible conformation have been 
repeatedly exploited.  
 
Earlier studies used radio-labeled or antibody-based detection methods followed by resolution 
polyacrylamide gel electrophoresis (PAGE). Conformation-sensitive PAGE, first developed by 
Rock and Cronan27 and subsequently markedly improved by Post-Beittenmiller et al 28 to study 
spinach acyl-ACP species, is still popular, and separation relies on the varied conformations of 
different acyl-ACPs. Although, still extremely effective for defined in vitro separations, this 
method requires authentic standards for each species being identified. Moreover, it suffers from 
poor resolution and limited predictability of the migration pattern of any given acyl-ACP.  
 
With the advent of more sophisticated mass spectrometric methods 29-31, efforts have been made 
to analyze the acylation pattern via liquid chromatography-mass chromatography under specific 
scenarios. These methods are extremely effective at identifying expected species but are severely 
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limited in their capacity to identify novel species. Unbiased approaches to differentiate all fatty 
acid intermediates suffer from poor reproducibility, require elaborate instrumentation and cannot 
be used in an ideal setting for determining intracellular fluxes.  
 
2.2 MATERIALS AND METHODS 
 
2.2.1 Bacterial Strains, Plasmids and Materials 
The bacterial strains used were derivatives of E. coli K-12, Bacillus subtilis 168, Pseudomonas 
aeruginosa PAO1, Enterococcus faecalis FA2-2, Clostridium acetobutylicum ATCC 824 and 
Agrobacterium fabrum C58 (Table 2.1). All strains were grown in LB media. C. acetobutylicum 
was grown anaerobically. The minimal medium for E. coli contained M9 salts, 0.4% glucose and 
0.1% Casamino acids. General defined media for B. subtilis was Spizizen salts32 consisting of 0.2 
% (NH4)2SO4, 1.4% K2HPO4, 0.6% KH2PO4, 0.1% sodium citrate · 2H2O, 0.02% MgSO4 · 7H2O] 
plus trace elements [MgCl2·6H2O, CaCl2, FeCl2·6H2O, MnCl2·4H2O, ZnCl2, CuCl2·2H2O, 
CoCl2.6H2O NaMoO4.2H2O], 0.4% glucose, and 1 mM MgSO4 · 7H2O and 0.01% tryptophan. 
Antibiotics were used in the following concentrations (in μg/ml): Zeocin (25), streptomycin (100), 
sodium ampicillin (100) and kanamycin sulfate (50). 
 
Plasmids pKD46, pKD13 and pCP20 were obtained from the E. coli Genetic Stock Center (CGSC) 
at Yale University while plasmid p7Z6 (BGSC ID ECE202) was obtained from the Bacillus 
Genetics Stock Center. Oligonucleotides were purchased from Integrated DNA Technologies. 
PCR amplification was performed using Q5 polymerase (New England BioLabs) according to the 
manufacturer's specifications. DNA constructs were sequenced by ACGT, Inc. Reagents and 
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chemicals were obtained from Sigma-Aldrich and Fisher Scientific, unless otherwise noted. New 
England BioLabs supplied restriction enzymes and T4 DNA ligase. StrepTrap HP (5ml) and 
HiTrap DEAE Sepharose FF were purchased from GE Healthcare. Anti-Strep antibody was 
purchased from IBA Lifesciences and all western blots were performed as per their protocols.  
 
The acpP and acpA genes were amplified from the E. coli MC1061 and B. subtilis 168 genomes 
by PCR using primer sets acpP BamHI F/acpP XhoI R and acpA BamHI F/acpA XhoI R, 
respectively, with the reverse primers adding a carboxy-terminal Strep-tag II.  These amplicons 
were digested with BamHI and XhoI and ligated with pET28a digested with the same enzymes to 
give pSW12 and pSW13, respectively. 
 
2.2.2 Construction of Strep-tagged ACP  
The acpP gene of E. coli MC1061 was tagged with a 24-nt strep-tag II sequence (encoding 
WSHPQFEK) with a 6 nt linker (encoding SA) placed before the stop codon of acpP. This was 
performed using the method of Datsenko and Wanner33 with PCR primers acpP P1 and acpP P2 
used to generate the recombinogenic PCR product with a 24-nt strep-tag II.  Recombinants were 
selected on kanamycin containing solid media and verified by sequencing to contain the Strep-tag 
at the correct genomic location. This strain was called SW12. and was further transformed by 
pCP20 to eliminate the antibiotic resistance marker resulting in strain SW13. 
  
The acpA gene of B. subtilis BSPC10 was tagged in an equivalent manner but using the method 
of Yan et. al 34 resulting in strain SW14. A fragment containing a Zeocin resistance gene flanked 
by lox sites was amplified from plasmid p7Z6 using primers acpA F2 and acpA R2. Five hundred 
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bp upstream and downstream fragments were amplified from the B. subtilis 168 genome using 
primer sets acpA F1/acpA R1 and acpA F3/acpA R3, respectively with the upstream fragment 
containing a 24-nt strep-tag II sequence (encoding WSHPQFEK) with a 6 nt linker (encoding SA) 
placed before the stop codon of acpA. Strain SW15 was generated by expressing the IPTG-
inducible Cre recombinase encoded on the genome, leaving behind only a lox72 scar on the 
genome downstream of the strep-tagged acpA gene. 
 
2.2.3 Growth Measurements 
Cultures were started in LB medium with the necessary supplements and antibiotics. Overnight 
cultures were diluted to an OD of 0.05 and growth was recorded by making optical density 
measurements every ten minutes using a Bioscreen C (Growth Curves USA) with rapid shaking 
for 7 h at 37˚C. All growth curves are plotted as an average of 5 identical samples. 
 
2.2.4 In vitro Fatty Acid Synthesis Assay 
The integrity of the Strep-tagged ACP was characterized using purified E. coli enzymes to carry 
the enzymes in fatty acid biosynthesis. To produce malonyl-ACP-S Tag, the fatty acid synthesis 
assay mixtures, which contained 0.1 M sodium phosphate (pH 7.0), 5 mM dithiothreitol, 2 µg 
holo-ACP-S Tag, and 400 μM malonyl-CoA and E. coli FabD (3 μg) in a final volume of 50 μL 
were incubated at 37°C for 1 h. Then, the following purified His-tagged E. coli proteins at 1 
μg/assay were added: FabG, FabH, FabA and FabI plus acetyl-CoA (400 μM).  NADH (200 μM) 
and NADPH (200 μM) were added to 30 µl of the previous reaction mixture and the volume was 
adjusted to 40 µl with H2O. The reaction mixtures were incubated at 37°C for 1 h. The reactions 
were stopped by placing on ice and mixed with gel loading buffer and analyzed by conformation-
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sensitive gel electrophoresis (CS-PAGE) on 20% polyacrylamide gels containing a 0.5 M urea 
28,35. The gels were stained and visualized using Coomassie Brilliant Blue (CBB). 
 
2.2.5 Radioactive Labeling of Phospholipids and ACP  
For labeling phospholipids, E. coli cultures were grown at 37°C in LB medium (1% tryptone, 0.5% 
yeast extract, 1% NaCl) with 5 μCi of sodium [1-14C] acetate until an optical density of 1.0 was 
attained. The phospholipids were extracted by the method of Bligh and Dyer 21, separated by thin-
layer chromatography and detected by phosphorscreen autoradiography using a GE Typhoon 
FLA7000 phosphorimager. The intensity of the spots was quantified using the Image Quant TL 
software (GE Healthcare) relative to the wildtype.  Radiolabeled fatty acids were purchased from 
Moravek Biochemicals. All thin-layer plates were scored into lanes to prevent cross-
contamination. 
 
Methionine auxotrophs of E. coli and B. subtilis were grown in 1 ml of LB media with 10 µCi of 
L-[35S]-methionine added. Growth was allowed to proceed until OD 1.0, and the cells were 
harvested by centrifugation. Cells were resuspended in 100 µl of 50 mM Tris-HCl buffer pH 8.0. 
Ten µl was used for measuring protein concentration using the Biuret method36. Ten µl of a fresh 
lysozyme stock (10 mg/ml) was added to the remaining cells, and the mixture was incubated on 
ice for 15 min. Eight µl of a 500 mM EDTA solution was added, gently mixed and further 
incubated on ice for 15 min. Bugbuster reagent (Novagen, 12µl of 10X) was added, and lysis was 
allowed to proceed at room temperature for 30 min. Lysed cultures were centrifuged at 4˚C for 30 
mins and their components were separated by CS-PAGE as described before. Gels were stained 
with CBB for direct visualization, while radioactive incorporation was visualized by 
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phosphoscreen autoradiography. EasyTag™ L-[35S]-methionine, 500 µCi (18.5MBq) was 
purchased from PerkinElmer. 
 
ACPs of several bacteria were specifically labelled with 14C-octanoic acid as follows. Bacterial 
cultures were grown to an OD of 1.0 in LB, and their cells collected by centrifugation. Cells were 
resuspended in 10 mM Tris-HCl buffer pH 10.0 containing 5 mM dithiothreitol, and they were 
lysed using multiple passes through a French pressure cell. The lysate was clarified by 
centrifugation and the cells were stored on ice for 8 h. The lysate was reclarified by centrifugation 
and was dialyzed overnight against 50 mM Tris-HCl buffer at pH 7.0 using a 1000 MWCO 
membrane. The resulting lysate was concentrated to roughly 40 mg/ml (measured by the micro-
biuret method) and stored at -20˚C for further use. A 50 µl reaction was setup to convert the apo-
ACP in the lysate to holo-ACP. The reaction mixture contained 40 µl of the lysate, 1 µg of purified 
B. subtilis Sfp, 10 mM MgCl2, 5 mM lithium CoA, 50 mM Tris pH 8.0 and 1 mM DTT, and the 
reaction proceeded at 37˚C for 2 h. Purified Vibrio harveyii Aas (5µg) was added to this together 
with 5 µCi of 14C-octanoic acid (Moravek Biochemicals) and further incubated at 37˚C for 4 h. 
The entirety of this reaction was separated by SDS-PAGE and visualized/quantified by 
phosphoscreen autoradiography as described earlier. 
 
2.2.6 Purification of Strep-tagged ACP 
All procedures were performed at 4C unless stated otherwise. The starting material for this 
purification was from cells obtained from 500 ml of E. coli or B. subtilis cultures at OD 1.0. Cells 
were resuspended in Buffer A (50 mM ammonium acetate pH 5.5) and lysed using a French 
pressure cell. For viscous preparations, the lysate was further subjected to sonication at the highest 
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permissible setting at a 100% duty cycle for 5-10 seconds. The lysate was then clarified by 
centrifugation at 48,400 x g for 30 min. The supernatant was recovered and subjected to a second 
round of centrifugation. 
 
The supernatant was applied to a 5 ml GE HiTrap DEAE FF column pre-equilibrated with buffer 
A. Elution fractions between 477 mM and 667 mM (IEX Fraction) were collected from a 50 mM-
1000 mM ammonium acetate salt gradient.  The IEX fraction was concentrated ten-fold in a 3 
MWCO ultrafiltration device and diluted to the original volume in Buffer C (150 mM ammonium 
acetate, 25 mM ammonium bicarbonate, pH ~7.4). This was then applied to a pre-equilibrated 5 
ml GE StrepTrap HP column. The column was further washed with buffer C until no material 
appeared in the effluent. ACP was selectively eluted using 2 column volumes of Buffer D (buffer 
C with 2.5 mM desthiobiotin). This was concentrated 20X using a 3 MWCO ultracentrifugation 
device and lyophilized for storage.  
 
2.2.7 Mass Spectral Analysis 
The lyophilized samples were resuspended in 10 mM ammonium bicarbonate and analyzed by 
direct infusion in to an Orbitrap Fusion Mass spectrometer. The mass spectrum was deconvoluted 
and analyzed using the Xcalibur 2.0 software. Acyl-modifications were assigned based on mass. 
The samples were additionally digested with the enzyme Glu-C, and the peptide fragments were 
subject to LC-MS and peptide mass fingerprinting using the MASCOT server (Matrix Science). 
This returned a set of post-translational modifications which was used to validate those observed 




2.3 EXPERIMENTAL RESULTS 
 
2.3.1 Carboxy-terminal Strep-tagged ACP is Functional in vivo 
The genomes of E. coli MC1061 and B. subtilis 168 were modified such that a Strep-tag II 
(WSHPQFEK) was introduced at the carboxy-terminus of their respective ACP encoding genes, 
acpP or acpA (Fig. 2.1A). The Strep-tag had no observable effect on growth in E. coli or B. subtilis 
(Fig. 2.1B). Since E. coli acpP is within the fatty acid operon, the effect of the tagging procedure 
was evaluated by use of the downstream gene fabF. A fabF mutant is deficient in producing C18:1 
fatty acids. While the presence of a kanamycin resistance gene, used as a selection for homologous 
recombination, significantly reduced cis-vaccenate levels (Fig. 2.2) in phospholipids, elimination 
of the kanamycin cassette restored wild type levels, indicating that the Strep-tag and downstream 
FRT scar did not affect fabF expression.  
 
2.3.2 Strep-tagged ACP is Easier to Measure and Visualize than its Native Form 
The native ACP protein in E. coli and B. subtilis lacks aromatic residues that are responsible for 
the typical protein absorbance measured at 280 nm and for binding with dyes like Coomassie 
brilliant blue. The Strep-tag II introduces a tryptophan residue that can overcome this 280 nm 
absorbance deficiency. Strep-tagged ACP also stained better in polyacrylamide gels than native 
ACP, and absorbance measurements led to a more accurate estimation of protein concentration. 
Further, the availability of a commercial antibody against the Strep-tag allows for easy 





2.3.3 Strep-tagged ACPs are Functional in vitro 
Strep-tagged ACP from E. coli (EcACP-STag) and B. subtilis (BsACP-STag) were obtained as a 
mixture of their apo and holo forms when overexpressed in and purified from E. coli BL21(Star). 
This indicates that the native E. coli AcpS can function on EcACP-STag and BsACP-STag in vivo. 
Both proteins could be completely converted to their holo form by the action of Sfp which could 
be separated on a CS-PAGE from the apo form. The purified ACP migrated at a slightly different 
distance on a urea containing polyacrylamide gel than their native forms. Holo-EcACP-STag was 
also used in an in vitro reconstituted fatty acid system wherein it was first converted to malonyl-
ACP using FabD and malonyl-CoA and finally extended to butyryl-ACP by the action of purified 
E. coli FabH, FabG, FabA and FabI (Fig. 2.3B). A similar result was observed with the BsACP-
STag protein (not shown). This demonstrates that the tag does not block the activity of  typical 
fatty acid enzymes. 
 
2.3.4 E. coli has Five to Ten-fold more ACP than B. subtilis 
Western blots of cellular lysates of SW13 and SW15, using antibodies targeting the Strep-tag, 
show much lower levels of ACP in B. subtilis in comparison to E. coli. The anti-Strep antibody 
however, can recognize both Strep-tagged ACPs equally (Fig 2.4). Densitometric calculations 
place ACP levels in B. subtilis to be around 8% of that in E. coli, when normalized against total 
cellular protein content. This was further confirmed by 35S-methionine labeling of total proteins in 
a B. subtilis 168 ∆metE strain and an E. coli BW25113 ∆metE strain and separating ACP from 
other cellular proteins by SDS-PAGE. Abundance counts of E. coli and B. subtilis ACP obtained 
by phosphorscreen autoradiography show that B. subtilis has roughly 18% of the ACP levels as 
those in E. coli.  ACP from cellular lysates of E. coli MG1655, B. subtilis 168, Pseudomonas 
33 
 
aeruginosa PAO1, Clostridium acetobutylicum ATCC 824, Enterococcus faecalis FA2-2 and 
Agrobacterium fabrum C58 were also specifically labeled with 14C-octanoic acid. This places B. 
subtilis ACP concentrations at 12% of that of E. coli (Fig. 2.4B). Surprisingly, similar ACP levels 
were also observed in P. aeruginosa (6%) and A. fabrum (18%). Interestingly, almost no signal 
was observed in E. faecalis and C. acetobutylicum lysates, indicating a lack of recognition by Sfp 
of these ACPs or a lack of sensitivity for very low ACP levels by this method (Fig. 2.4C). To see 
if this difference in protein levels is due to transcriptional regulation, a quantitative RT-PCR was 
performed with protein normalized RNA isolated from E. coli MC1061 and B. subtilis 168. The 
acpP mRNA levels in E. coli were roughly twice that of acpA from B. subtilis  
  
2.3.5 The ACP Interactome of B. subtilis 
Studies in E. coli have shown that ACP is extremely interactive with other proteins. In B. subtilis 
we observe that ACP interacts with a large number of proteins (Table 2.4). Most of these proteins 
play a direct role in fatty acid biosynthesis and include FabF, FabH1, FabH2, FabG and FabI (Fig. 
2.5B). FabZ was identified after the affinity purification but not after size exclusion 
chromatography. Other enzymes such as the different subunits of the pyruvate dehydrogenase 
complex, ribosomal proteins, sugar transport related proteins and certain unknown proteins are 
also associated with ACP. The veracity of these interactions has not been verified.    
 
2.3.6 FabF Tightly Associates with B. subtilis ACP in a Stoichiometric Fashion  
A contaminating band was consistently found in purified B. subtilis ACP preparations. These were 
often identified to be cold shock proteins that are similar in size. However, one ‘contaminant’ 
persisted through multiple purification columns and was identified to be B. subtilis FabF by peptide 
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mass fingerprinting. In fact, when ACP was purified directly from the streptactin column, FabF 
was co-purified in a 1:2 ratio. This is expected because FabF is a dimer. In fact, when incubated 
in vitro purified FabF and ACP were observed to migrate as a single peak during gel filtration (Fig. 
2.5A). Attempts to crystallize this complex have thus far failed. A similar interaction between E. 
coli FabF and ACP was not observed. 
 
2.3.7 Purification of Acyl-ACP species from E. coli and B. subtilis 
An ammonium acetate buffer at pH 5.5 was chosen to lyse the cells grown in the condition to be 
tested. Malonyl-ACP, prepared in vitro, was found to be stable in this buffer when tested after a 
24 h incubation at 4˚C, corresponding to the average length of purification. The lysate was clarified 
by ion-exchange chromatography using a DEAE Sepharose column. The chromatography 
conditions were systematically tested in E. coli to ensure complete recovery of acyl-ACPs while 
eliminating as many contaminating proteins as possible. For E. coli, the optimal window for elution 
was between 450 mM and 650 mM ammonium acetate. B. subtilis required a more relaxed window 
of elution between 350 mM and 650 mM ammonium acetate (Fig. 2.7A). Complete recovery was 
confirmed by monitoring all fractions for ACP by CS-PAGE (Fig. 2.7B).  However, a significant 
level of contaminating protein was still seen after this step.  
 
Binding to the streptactin column requires a pH above 7. To ensure optimum binding without 
thioester hydrolysis, the stability of pure malonyl-ACP was tested in buffers containing various 
proportions of ammonium acetate and ammonium bicarbonate. Malonyl-ACP was found to be 
stable for at least 12 h (maximum time tested) in a 150 mM ammonium acetate and 25 mM 
ammonium bicarbonate buffer that has a pH of ~ 7.4. To minimize handling time at the higher pH, 
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the eluate from the ion-exchange column was concentrated ten-fold in a 3 kDa spin column, diluted 
in the above-mentioned buffer to the original volume and directly injected into an equilibrated 
streptactin column. Acyl-ACPs were eluted with 2.5 mM desthiobiotin after washing the column 
until a flat baseline was achieved (Fig. 2.7A). The eluate was free of contaminants and gave a 
single band when visualized by CS-PAGE (Fig. 2.7B). This was also confirmed by peptide mass 
fingerprinting. The purified acyl-ACPs were immediately lyophilized for further analysis. 
 
2.3.8 Mass Spectrometric Analysis and Validation 
The lyophilized samples were dissolved in 10 mM ammonium bicarbonate buffer with formic acid 
and directly injected into an Orbitrap-based mass spectrometer. Acyl-ACP identifications were 
made based on mass. In E. coli, very little or no apo-ACP was observed. The major species 
observed at every stage of growth were, however, acetyl ACP. Some malonyl-ACP was detected 
as well. Acetyl-ACP remains the major species in E. coli from early exponential growth until 
stationary growth. Longer chain saturated fatty acids (14-18 carbon length) were mainly observed 
earlier during growth with shorter chain accumulating as growth progressed. The levels of 
malonyl-ACP remained stable regardless of growth phase except during the stationary phase 
wherein it diminishes by 60-70% of earlier levels. Interestingly, during early growth, E. coli 
accumulated some decanoyl-ACP (16%) which fell to 5% or less as exponential growth continued 
into stationary phase.  
 
In B. subtilis, acyl-ACP yields are much lower, but the signal/noise ratio observed during mass 
spectrometry remains the same. In fact, the major species of B. subtilis is also acetyl-ACP. Other 
acyl-ACP species were also reliably observed. 
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2.3.9 The Metabolic Role of Acetyl-ACP 
Acetyl-ACP remains the predominant species in both bacteria. In E. coli, acetyl-ACP is observed 
across its various stages of growth in rich media. Purified malonyl-ACP has been shown to be 
stable under purification conditions. Acetyl-ACP is observed in E. coli even if the culture is 
instantly lysed using 10% TCA followed by an acetone wash before extraction. This suggests that 
acetyl-ACP is an authentic product of metabolism present in the cell. The source and role of acetyl-




Fatty acid synthesis is a vital pathway in bacteria which primarily feeds phospholipid synthesis 
along with other dependent pathways like vitamin synthesis, lipid A synthesis and quorum sensing 
amongst others. The intermediates of this pathway are covalently liked to ACP via a thioester 
bond. Even though ACP is easily purified due to its small size and acidic nature, preservation of 
the thioester bond can be difficult under in vitro conditions.  
 
In this Chapter, I describe a method for isolating acyl-ACPs in an extremely pure manner while 
maintaining the thioester bond and the ensuing acyl modifications of ACP. This required the 
introduction of an inert Strep-tag onto the ACP protein, which could be then be isolated using a 
Streptactin column that can specifically recognize the Strep-tag with high affinity but be eluted 
with a small non-reactive molecule, desthiobiotin (while desthiobiotin can be removed from the 
Streptactin column under alkaline conditions, biotin binds it irreversibly). Hence, to clarify the 
lysate while removing biotin present in it, the samples were first subjected to anion-exchange 
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chromatography.  Previous attempts to use a strong ion-exchanger resulted in increased 
contamination with small RNA fragments (Table 2.5) that possess a similar acidic charge. Hence, 
a weak ion-exchanger like DEAE was preferred.  New variants of Streptactin, called Streptactin 
XT, are now available that can be directly eluted with biotin.  
 
A volatile buffer system (ammonium acetate:acetic acid) was chosen with a pH of 5.5 to preserve 
the thioester bond. However, the biggest and only limitation of using the Strep-tag for this 
particular purpose is its requirement for a pH above 6.5 to bind to the streptactin column. Hence, 
the pH was adjusted to 7.5 using ammonium bicarbonate after ion exchange chromatography. 
Other affinity tags like the hexahistidine tag also have this requirement. In addition, the imidazole 
eluant would hydrolyze the thioester and is hence avoided (Table 2.5). The low pH during the 
initial step served to reduce contaminant binding during anion-exchange and the pH shift after that 
step additionally destabilized other contaminant proteins that had an isoelectric point within this 
range. Ammonium acetate was preferred over buffers with sodium and potassium ions to avoid 
the formation of stable salt bridges with the ACP species. Though, Na+ and K+ can improve 
ionization during mass spectrometry, salt bridges can severely convolute peak assignment during 
identification of novel species.  
 
E. coli ACP is an extremely abundant protein with 60,000 copies per cell. However, such data are 
unavailable in other organisms. Our data indicate that B. subtilis consistently has five to ten-fold 
lower total ACP levels than E. coli. The true value is probably closer to ten-fold, since cold-shock 
proteins expressed during handling are a major contaminant of ACP preparations in B. subtilis and 
run with the same mobility as ACP in CS-PAGE. Our preliminary evidence using 14C-octanoic 
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acid labelling of the ACP thiol shows that this might be the case in several other Gram-positive 
and Gram-negative organisms. In fact, we observe little to no ACP in Clostridium acetobutylicum 
and Enterococcus faecalis when normalized to total protein content. ACP is found to associate 
strongly with FabF both in vivo and in vitro. However, the reciprocal experiment wherein FabF is 
tagged with a Strep-tag at its carboxy terminus on the genome and ACP is expected to co-elute, 
has proved difficult. The tag at the C-terminus remains inaccessible to the column even with the 
use of longer linkers, and almost no FabF can be isolated from B. subtilis. One speculation is that 
ACP binding to FabF results in the tag being buried in the protein-protein interface.  B. subtilis 
ACP can also be reliably pulled down with the other fatty acid synthesis proteins. In addition, 
proteins like the biotin carboxylase carrier protein and pyruvate dehydrogenase were also isolated, 
suggesting that some indirect interactions were also captured. Our method to identify acyl-ACPs 
was also effective in B. subtilis, regardless of its lower ACP levels, suggesting that this 
methodology can be scaled while retaining its sensitivity.   
 
Previous reports suggested that the majority of ACP in E. coli exists in its holo form with only a 
small population being acylated 37. These studies used CS-PAGEs to make these estimates, and 
acetyl-ACP migrates similar to holo-ACP on a CS-PAGE under most conditions. On the contrary, 
we observe that a majority of the ACP in E. coli exists as acetyl-ACP. Acetyl-ACP was suggested 
to be the original primer for fatty acid initiation. This theory had fallen out of favor when it was 
demonstrated in in vitro that FabH can only function with acetyl-CoA, with more than 90% of the 
fatty acid flux flowing through this enzyme. 10% of the total enzymatic activity of FabH is a  
transacylase activity that can convert acetyl-CoA to acetyl-ACP. Also, malonyl-ACP could 
spontaneously decarboxylate in vivo to give acetyl-ACP. However, fabH can be knocked out in E. 
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coli with no significant defect, and malonyl-ACP is an expensive species to accumulate since the 
generation of each malonyl moiety requires one ATP molecule. The metabolic role and the source 
of acetyl-ACP and the true initiator of fatty acid synthesis is yet to be characterized. 
 
Similar observations of acetyl-ACP are also made in B. subtilis, suggesting a commonality 
between E. coli and B. subtilis in this regard. Bacillus species produce very little straight-chain 
fatty acids. These straight-chain fatty acids might only be required for associated pathways like 
biotin synthesis and lipoic acid synthesis, but these pathways also maintain other redundant 
mechanisms26,38-40. A study reports the creation of a double knockout of fabHA and fabHB in B. 
subtilis that can be stably grown in the presence of long chain branched fatty acids41. This strain 
is reported to still incorporate straight chain fatty acids in its membrane, suggesting that a novel 
initiation mechanism might indeed exist. Our method opens up the possibility of examining 
bacteria like E. coli and B. subtilis under new light. With minor genomic modifications, these 
bacteria can be tested under numerous external conditions including the effect of novel antibiotics, 
with the method itself being agnostic to the treatment. Additionally, better metabolic models can 
be built with these data sets, possibly revealing novel modes of regulation and improving their 




2.5 TABLES AND FIGURES 
 
Strains Relevant Genotype Source 
MC1061 Wild type strain Casadaban, et 
al., 1980 




MG1655 K-12 F– λ– ilvG– rfb-50 rph-1 CGSC #6300 
BL21 (Star) ompT hsdSB (rB-, mB-) gal dcm rne131 (DE3) Invitrogen 
SW12 MC1061 acpP-StrepTag::FRT-KanR-FRT This work 
SW13 MC1061 acpP-StrepTag::FRT This work 
SW14 BS168 acpA-StrepTag::lox69-StrR-lox71 This work 
SW15 BS168 acpA-StrepTag::lox72 This work 
JW3805 BW25113 ∆metE::Kan CGSC# 10758 
BKK13180 BS168 ∆metE::Kan BGSC 
BS168 B. subtilis wildtype strain; trpC auxotroph BGSC 
BSPC10 BS168 ∆amyE::pSpac-Cre SpecR BGSC 








Plasmids Relevant Characteristics Source 
pBAD24 AmpR, Arabinose-inducible expression vector Guzman, et 
al., 1995 
pET28b KanR, T7 promoter-based, IPTG inducible expression 
vector 
Novagen 
pSW04 KanR, N-terminal hexahistidine-tagged E. coli fabG gene 
in pET28a 
Srinivas et. al, 
2017  
pSW05 KanR, N-terminal hexahistidine-tagged E. coli fabD gene 
in pET28a 
Srinivas et. al, 
2017  
pSW06 KanR, N-terminal hexahistidine-tagged E. coli fabH gene 
in pET28a 
Srinivas et. al, 
2017  
pSW07 KanR, N-terminal hexahistidine-tagged E. coli fabA gene 
in pET28a 
Srinivas et. al, 
2017  
pSW08 KanR, N-terminal hexahistidine-tagged E. coli fabI gene in 
pET28a 
Srinivas et. al, 
2017  
pSW12 KanR; PCR amplified Ec acpP with C-terminal Strep-tag 
in BamHI/XhoI sites of pET28a 
This work 
pSW13 KanR; PCR amplified Bs acpA with C-terminal Strep-tag 
in BamHI/XhoI sites of pET28a 
This work 




pKD13 Pir dependent plasmid that has FRT-KanR-FRT cassette  Datsenko and 
Wanner, 2000 
P7Z6 AmpR; plasmid carrier lox69-ZeoR-lox71 cassette Yan et. al, 
2008 
 
















acpA F2 GAGCTCGGTACCCGGGGATCCT 
acpA R2 GCTTGCATGCCTGCAGGTCGAC 
acpA F3 GTAGAATCGTCGACCTGCAGGC GCTGATG CTAAAAGTCCCG 
acpA R3 CGCCTTTACCCAACAGGA 
acpP BamHI F ACGTCAGGATCCATGAGCACTATCGAAGAACG 
acpP XhoI R GCTACACTCGAGTTATTTTTCGAACTGCGGGTGGCTCCACGCTG
ACGCCTGGTGGCCGTTGAT 
acpA BamHI F ACGTCAGGATCCATGGCAGACACATTAGAGC 
acpA XhoI R GCTACACTCGAGTTATTTTTCGAACTGCGGGTGGCTCCACGCTG
ATTGCTGGTTTTGTATGTAGTTCAC 
Ec AcpP RT F CTGGTAATGGCTCTGGAAGAAG 
Ec AcpP RT R CTGGTGGCCGTTGATGTAAT 
Bs AcpA RT F GCAGACACATTAGAGCGTGTA 
Bs AcpA RT R CATCTAGGGAATCAGCACCTAAG 
 




Protein name Function Pathway Counts 
FabF β-ketoacyl-ACP synthase II Fatty acid synthesis 16638 
ACP Acyl carrier protein Fatty acid synthesis 8562 
FabH1 β-ketoacyl-ACP synthase III Fatty acid synthesis 630 
FabG β-ketoacyl-ACP reductase Fatty acid synthesis 532 
PdhC Pyruvate dehydrogenase E2 subunit Lipoic acid synthesis 476 
PdhB Pyruvate dehydrogenase E1β subunit Lipoic acid synthesis 397 
HepS Heptaprenyl diphosphate synthase Isoprenoid synthesis 397 
DegU Two-component response regulator Catabolite repression by 
glucose 
324 
PdhA Pyruvate dehydrogenase E1α subunit Lipoic acid synthesis 321 
CarA Carbamoyl-phosphate synthase Pyrimidine biosynthesis 292 
PtsI Phosphoenolpyruvate—protein 
phosphotransferase 
Sugar transport 240 
RL7 50S Ribosomal subunit L7 Protein synthesis 231 
FabH2 β-ketoacyl-ACP synthase III Fatty acid synthesis 212 
GlyA Serine hydroxymethyltransferase Purine synthesis  177 
PdhD Dihydrolipoyl dehydrogenase Lipoic acid synthesis 175 
BCCP Biotin carboxyl carrier protein Fatty acid synthesis 173 
EftU Elongation factor Tu 1 Protein synthesis 152 
YdbB Putative Mn-binding protein Unknown function 125 
CspC Cold shock-like protein Cold adaptation 121 
FabI Enoyl-ACP reductase Fatty acid synthesis 111 
MurB UDP-N- acetylenol-
pyruvoylglucosamine reductase 
Cell wall synthesis 109 
YhfS Putative acetyl-CoA acetyltransferase Fatty acid metabolism 107 
RS2 30S Ribosomal protein S2 Protein synthesis 88 
Eno Enolase Glycolysis 84 
 




Purification Condition Concerns  
Ion-exchange counterions Contamination by RNA fragments with strong counterions  
Buffer pH pH above 7.5 can cause thioester hydrolysis 
Buffer composition Salts like imidazole can cause thioester hydrolysis 
Buffer ions Salt adduct formation can convolute spectral analysis 
Size exclusion High contaminant levels; Increase in signal/noise ratio during MS  
 



















Figure 2.1 Effect of Strep-tag on ACP function in vivo. A) The fatty acid biosynthetic operons 
of E. coli and B. subtilis are visualized here with the scar left from the tagging methodology 
indicated as a black box. The E. coli operon has a FRT site between acpP and fabF. B. subtilis has 
a lox72 scar downstream of acpA. B) Growth curve of wildtype B. subtilis 168 compared to that 
with a Strep-tag at the carboxy terminus of ACP C) Growth curve of wildtype E. coli MC1061 









Figure 2.2 acpP tagging in E. coli has no polarity on downstream genes.  An autoradiograph 
of fatty acid methyl esters from phospholipids isolated from strains grown in 14C-sodium acetate 
and separated by Ag-thin layer chromatography. Wildtype E. coli MC1061 has saturated fatty 
acids (SFA), cis-vaccenic acid (C18:1) and palmitoleic acid (C16:1), while MC1061 with a 
kanamycin resistance cassette between the tagged acpP gene and fabF is polar (Lanes 2 and 3). 




Figure 2.3 Strep-tagged ACP is functional in vitro. A) SDS-PAGE and western blot detection 
of ACP from E. coli with Strep-tagged ACP. Strep-tagged ACP runs with an apparent molecular 
weight around 17.5 kDa due to its acidic nature. B) Apo-, holo- and malonyl-ACP visualized by 
conformationally-sensitive PAGE (Lanes 1-3). Malonyl-ACP-S Tag along with acetyl-CoA is 












Figure 2.4 Relative amounts of ACP in E. coli and B. subtilis. A) Western blot using a Strep-
tag-specific antibody in cell lysates of E. coli and B. subtilis. Purified proteins are loaded as 
controls for antibody specificity. B) 35S-labeled total proteins separated by CS-PAGE. Purified 
Strep-tagged ACP from E. coli and B. subtilis is loaded on the same gel to calculate migration 
distance. Labeled bands corresponding to ACP are quantified using phosphorscreen 
autoradiography. C) 14C-Octanoate labeled ACP from cellular lysates of multiple bacteria. 
Quantifications were done using phosphorscreen autoradiography and are indicated above each 









Figure 2.5 B. subtilis ACP interacts tightly with some of its partners. A) Size Exclusion 
Chromatogram of in vitro co-incubation of FabF and ACP.  FabF and ACP elute as one large peak 
with a size corresponding to a dimer of FabF and one unit of ACP. B) A schematic of proteins 
involved in fatty acid biosynthesis that co-elute with B. subtilis ACP. A loose complex is proposed, 












Figure 2.6 Schematic of acyl-ACP purification with final buffer conditions indicated 




Figure 2.7 Efficiency of the acyl-ACP purification process.  A) Chromatographic profiles of 
ion-exchange chromatography and affinity chromatography with the desired fractions indicated 
with a dotted box. B) Desired fraction from each step visualized by CS-PAGE. Contaminants are 








Figure 2.8 A snapshot of acyl-ACPs identified during various stages of growth in E. coli. A 
graph depicting the ratio of apo-, holo- and acyl-ACPs to the total ACP detected during mass 














AN EIGHT RESIDUE DELETION IN ESCHERICHIA COLI FABG 
CAUSES TEMPERATURE-SENSITIVE GROWTH AND LIPID 





As discussed in Chapter 1, bacteria and plants utilize type II fatty acid synthesis (FAS), a 
dissociated system of individual enzymes, to generate the entire fatty acid repertoire from acetyl-
CoA. The intermediates are elongated by a series of four enzymes while being covalently bound 
to the acyl carrier protein (ACP) 8,42 via a thioester linkage. In Escherichia coli, a ß-keto acyl-ACP 
synthase (FabH, FabB or FabF) catalyzes a Claisen elongation reaction, that converts a growing 
acyl-ACP to its ß-ketoacyl form. The resulting ß-keto group is then reduced by a ß-ketoacyl-ACP 
reductase (FabG) 43 in a NADPH-dependent manner to a ß-hydroxyl group. The resulting 
intermediate is dehydrated by a ß-hydroxyacyl-ACP dehydratase (FabA or FabZ) to an enoyl-ACP 
and finally reduced again by an enoyl-ACP reductase (FabI), in a NADH-dependent reaction, to 
give an acyl-ACP that is two carbons longer and poised to re-enter the cycle until the appropriate 
chain length for complex lipid synthesis is achieved. Some of the early intermediates are siphoned 
off by FAS-dependent synthetic pathways such as those for biotin 44 and lipoic acid 44, whereas 
longer fatty acids are predominantly utilized for the synthesis of the membrane components, lipid 




FabG is a member of the short-chain dehydrogenase/reductase enzyme family (SDR), which carry 
out a variety of dehydrogenation and reduction reactions using a nucleotide cofactor 46. E. coli 
FabG is functionally active as a dimer of dimers with structural studies suggesting allosteric 
regulation induced by conformation changes within the tetramer 47. Though FabG is an essential 
enzyme, like most fatty acid synthesis enzymes, it is highly conserved across species and is the 
only isoform required for all ß-keto acyl-ACP reductions in the FAS pathway 48. An earlier study 
establishing the role of fabG in FAS isolated several temperature-sensitive (Ts) point mutants in 
E. coli (E233K) and Salmonella enterica (S224F; M125I and A223T) by a tritium suicide selection 
49. Most reported Ts mutants, produce proteins with missense mutations predicted by 
computational modeling 50 to cause large changes in denaturation temperatures. In the case of 
FabG, the Ts mutants produce extremely unstable and thermolabile proteins that very rarely 
survive purification and enzymatic characterization, even when produced and assayed at 
permissive temperatures 49.  
 
In this chapter, I report the detection, construction and biochemical characterization of fabG∆8 
which encodes a FabG that lacks eight residues that form part of an important helix-turn-helix 
motif that participates in dimerization, allostery and formation of the entrance to the active-site 
tunnel.  Only a handful of Ts mutations have been isolated that are caused by partial deletions and 
the Ts phenotype is usually the result of impaired subunit interactions 51 or decreased protein 
stability at higher temperatures 52. Understanding the mechanism of temperature-sensitivity in 
FabG∆8 increases our knowledge of intra-subunit interactions in the FabG tetramer and their 




In addition, I also demonstrate the suppressive influence of FabG in a lipid A biosynthetic mutant 
(lpxC101) 53 and its modulation of lipid A composition as a basis of conferring trifluoperazine 
(TFP) resistance, an inhibitor of mammalian calmodulin, to a E. coli lpxC101 strain 54. Since both 
FabG and LpxC are essential for growth and do not share homology with any known mammalian 
proteins, better understanding their interactions may give novel targets for the development of 
antibiotics that target multidrug-resistant Gram-negative pathogens. 
 
3.2 MATERIALS AND METHODS 
 
3.2.1 Bacterial Strains, Plasmids and Materials  
The bacterial strains used were derivatives of E. coli K-12 (Table 3.1) and were grown in LB 
medium. Medium additives (in μg/ml) were sodium ampicillin, 100; spectinomycin sulfate, 100; 
trifluoperazine dihydrochloride, 50; and kanamycin sulfate, 50. Oligonucleotides were purchased 
from Integrated DNA Technologies. PCR amplification was performed using Q5 polymerase 
(New England BioLabs) according to the manufacturer's specifications. DNA constructs were 
sequenced by ACGT, Inc. Reagents and chemicals were obtained from Sigma-Aldrich and Fisher 
Scientific, unless otherwise noted. New England BioLabs supplied restriction enzymes and T4 
DNA ligase. pCRISPR and pCas9 were a gift from Luciano Marraffini (Addgene plasmids 42875 
and 42876)  
 
The fabG∆8 gene was amplified via PCR from strain SW01 using primers fabG BspH1 F and fabG 
Sph1 R. The product was digested with restriction enzymes BspHI and SphI and inserted into the 
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NcoI and SphI sites of vector pBAD24 to generate pSW01. The wild type fabG gene was amplified 
from E. coli MC1061 using the same primers and vector to give pSW02.  Similarly, plasmids 
pSW03 and pSW04 were constructed to carry the fabGΔ8 gene or the wild type fabG, respectively. 
The genes were amplified using primer sets fabG BamHI F and fabG XhoI R and the products 
were inserted between the BamHI and XhoI sites of vector pET28a. Plasmids pSW05 to pSW08 
were constructed carrying E. coli genes fabD, fabH, fabA or fabI, respectively, using the same 
protocol. 
 
3.2.2 Construction of E. coli MC1061 fabG∆8 using CRISPR/Cas9 
A CRISPR gRNA insert targeting fabG was synthesized by heating single-stranded oligos, CR 
fabG S and CR fabG AS, together for 5 minutes at 99ºC and then slowly cooling to room 
temperature over 2 h. The insert was then phosphorylated using T4 polynucleotide kinase. The 
phosphorylated insert was then ligated to pCRISPR 55, digested with BsaI, to generate pCRISPR-
fabG. MC1061 transformed with pCas9 55 (a plasmid expressing both Cas9 and the tracrRNA) and 
pKD46, a plasmid expressing λ-red under arabinose control 33, was used to prepare 
electrocompetent cells. These cells were transformed with 100 ng of pCRISPR-fabG and 100 ng 
of oligo fabG HR and allowed to recover at 25ºC for 3 h. Transformants were selected on plates 
containing kanamycin and the colonies were screened for temperature-sensitivity at 42ºC. Positive 
colonies were verified by sequencing of PCR products to confirm the expected deletion. The final 
strain was cured of the plasmids by serial passages in LB medium followed by screening for loss 





3.2.3 Structural Modeling and Sequence Alignment 
The FabG∆8 sequence was structurally modeled to the E. coli FabG crystal structure (PDB 1I01) 
using Swiss-Model automated mode 56-59. The final image was created using VMD 60. Sequence 
alignments were created using Clustal Omega (http://www.ebi.ac.uk/Tools/msa/clustalo/) 
 
3.2.4 Expression and Purification of a His-tagged FabGΔ8 Protein 
Strain SW01 carrying plasmids pSW03 and pTara-Spec was grown in 1 L of LB-kanamycin 
medium containing 2 mM arabinose at 25°C to an OD600 of 0.8 and induced with 1 mM isopropyl-
β-D-thiogalactopyranoside for a further 24 h. The cells were pelleted, washed in an equal volume 
of lysis buffer (50 mM sodium phosphate, 300 mM sodium chloride, 1 mM tris(2-
carboxyethyl)phosphine HCl, 10% glycerol, pH 7) and concentrated 40-fold in the same buffer. 
Two passes through a French pressure cell was used to lyse the cells and the suspension was 
centrifuged twice at 48,400 x g) for 30 min each. The cleared supernatant was applied to a 5 ml 
GE His-Trap HP column pre-equilibrated with the lysis buffer. The column was washed stepwise 
with lysis buffer containing increasing amounts of imidazole (50 mM, 100 mM, 150 mM and 200 
mM) and FabGΔ8 was eluted with buffer containing 250 mM imidazole. The protein was 
concentrated to a final concentration of 3 mg/ml in an Amicon 10K centrifugal filter unit and 
dialyzed overnight against a 50 mM sodium phosphate buffer containing 500 mM sodium chloride, 
1 mM tris(2-carboxyethyl) phosphine HCl, 30% glycerol, pH 7 for subsequent storage at -80°C.  
Wild type E. coli FabG was purified in a similar manner from strain MC1061 carrying plasmids 
pSW04 and pCY560 grown at 37°C with 2 mM arabinose to OD600 of 0.8 followed by induction 
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with 1 mM isopropyl-β-D-thiogalactopyranoside for a further 3 h. All other fatty acid synthetic 
proteins were purified in a similar manner following overexpression in BL21 Star for 3 h at 37°C. 
 
3.2.5 Size Exclusion Chromatography 
Purified proteins (1 mg) were applied to a Superdex 200 (10/300) column (GE Healthcare) 
equilibrated with a 50 mM sodium phosphate buffer (pH 7) containing 300 mM sodium chloride, 
at a flow-rate of 0.5 ml/min. Protein elution was monitored by absorbance at 280 nm. The mixture 
of molecular weight standards and Blue Dextran were run in the same manner except that using 4 
mg of the mixture of standard proteins and 1 mg of Blue Dextran, respectively were loaded on the 
column. The void volume was calculated using the major absorbance peak of Blue-Dextran 
measured at 280 nm. The individual species were quantified using the area under their respective 
curves and expressed as a percentage of the total injected protein.   
 
3.2.6 Isolation of Phospholipids and Lipid A 
Cultures (25 ml) of strains D21, D22 and OMG3053 were grown in LB medium to an OD600 of 
0.6 at 25˚C. The cells were harvested by centrifugation and washed with cold phosphate buffered 
saline. The cells were then suspended in 1ml of phosphate buffered saline and mixed with 3 ml of 
a 2:1 mixture of chloroform-methanol to generate a single-phase Bligh-Dyer mixture 21. After 
standing for 15 min, the mixture was centrifuged at 4700 x g) for 15 min. The supernatant 
containing most of the phospholipids was converted to a two-phase Bligh-Dyer mixture 21 by 
adding 1 ml of chloroform and 1 ml of H2O, while the insoluble material was retained to isolate 
lipid A. The lower phase was carefully siphoned, and the phospholipid mixture was dried under a 
N2 stream and preserved at -80˚C for mass spectral analysis.  The insoluble pellet containing the 
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lipopolysaccharide with its covalently-bound lipid A moiety, was washed once with a single- phase 
Bligh-Dyer mixture, consisting of CHCl3/MeOH/H2O (2:1:1 v/v/v) and again recovered by 
centrifugation. The washed pellets were suspended in 0.12 ml of 12.5 mM sodium acetate, 1% 
sodium dodecyl sulfate, pH 4.5 and sonicated briefly for 30 sec. The suspension was heated to 
99˚C for 30 min, cooled and the volume adjusted to 0.36 ml. This was converted to a two-phase 
Bligh-Dyer mixture by adding 0.4 ml of chloroform and 0.4 ml of methanol. The phases were 
thoroughly mixed, and the mixture separated by centrifugation at 4700 x g) for 15 min. The lower 
phase was dried under a N2 stream. To reduce the amount of SDS, the dried material was dissolved 
in 0.36 ml of chloroform/methanol (1:1 v/v) and subsequently converted to a two-phase Bligh-
Dyer mixture by the addition of 0.4 ml of chloroform and 0.4 ml of methanol. The lower phase 
was recovered and dried under a N2 stream and the resulting crude lipid A was preserved at -80˚C 
for further analysis by mass spectral analyses.  
 
3.2.7 Mass Spectrometry 
Electrospray ionization mass spectrometry was carried out on a Waters Quattro Ultima using the 
negative ion mode. Phospholipid samples were dissolved in chloroform/methanol (2:1 v/v) and 
infused into the source at a flow rate of 10 µl/min using a syringe pump. MS spectra were acquired 
with a cone voltage of 30V or 225V, over the range m/z 100-1000, in 1s. Scans over a 2 min 
acquisition were combined. 
 
Matrix-assisted laser desorption ionization/time of flight mass spectra was acquired in a Brucker 
Daltonics UltrafleXtreme in the negative ion linear mode. The samples were prepared for 
MALDI/TOF by depositing 0.3µl of the lipid A sample dissolved in chloroform/methanol (2:1 
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v/v) followed by 0.3 µl of a saturated solution of the matrix, 2,5-dihydroxybenzoic acid in 50% 
acetonitrile. The sample was left to dry at room temperature. Spectra acquired were the average of 
50 laser shots. 
 
3.2.8 Radioactive Labeling of Phospholipids 
The cultures were grown at 25°C in LB medium (1% tryptone, 0.5% yeast extract, 1% NaCl) to 
mid log phase and then shifted to 42°C. After 2 h, 5 μCi of sodium [1-14C]acetate was added, and 
growth was allowed to continue for 2 h. The phospholipids were extracted by the method of Bligh 
and Dyer 21, separated by thin-layer chromatography and detected by PhosphorScreen 
autoradiography using a GE Typhoon FLA7000 phosphorimager. The intensity of the spots was 
quantified using the Image Quant TL software (GE Healthcare) relative to the wildtype.  
Radiolabeled fatty acids were purchased from Moravek Biochemicals. All thin-layer plates were 
scored into lanes to prevent cross-contamination. 
 
3.2.9 Spectrophotometric Assay of β-Ketoacyl-ACP Reductase Activity 
To measure activity spectrophotometrically, the oxidation of the cofactor NADPH was monitored 
at 340 nm. Reaction contained 300 µM acetoacetyl-CoA and 150 µM NADP(H) in a 100 mM 
sodium phosphate buffer at pH 7.0. Reaction was blanked without enzyme and FabG (0.1 µg) or 
FabG∆8 (0.1 µg or 1 µg) was added. To test the effect of TFP on FabG, 10X molar excess of TFP 
was pre-incubated with the enzyme on ice for 15 min before addition to the reaction. The final 





3.2.10 In vitro Fatty Acid Synthesis Assay 
β-Ketoacyl-ACP reductase activity was characterized using purified E. coli enzymes to catalyze 
steps in fatty acid biosynthesis. To produce malonyl-ACP, the fatty acid synthesis assay mixtures, 
which contained 0.1 M sodium phosphate (pH 7.0), 5 mM dithiothreitol, 2µg holo-ACP, and 
400 μM malonyl-CoA and E. coli FabD (3 μg) in a final volume of 50 μL were incubated at 37°C 
for 1 h. Then, purified His-tagged E. coli proteins FabG∆8 (2 μg/assay), and the following E. coli 
proteins at 1μg/assay FabH, FabA and FabI plus acetyl-CoA (400 μM).  NADH (200 μM) and 
NADPH (200 μM) were added to 30 µl of the previous reaction mixture and the volume was 
adjusted to 40 µl with H2O. Wild type E. coli FabG was used as a control. For calcium sensitivity 
experiments CaCl2 was added to a final concentration of (0.1, 1 or 10 mM) and pre-incubated with 
the enzyme for 15 min at 25°C. The reaction mixtures were incubated at 25°C for 2 h (or 42°C for 
45 min). The reactions were stopped by placing on ice and mixed with gel loading buffer and 
analyzed by conformation-sensitive gel electrophoresis on 20% polyacrylamide gels containing a 
0.5 M urea 28,35. The gels were stained and visualized using Coomassie Brilliant Blue. 
 
3.2.11 Chemical Cross-linking of FabG 
Purified mutant FabG (30 µM) was incubated at 25°C (or 42°C) for 15 min. Various concentrations 
of ethylene glycol bis[succinimidylsuccinate] (EGS) (0, 0.5, 2.5, 5 mM) were added and incubated 
at 25°C for 30 min or 42°C for 5 min. SDS-loading dye was added and samples were heated to 
99°C for 5 min. Samples were loaded on 4–20% gradient SDS polyacrylamide gels (Bio-Rad) and 





3.3 EXPERIMENTAL RESULTS 
 
3.3.1 The tfpA1 Mutation of Strain OMG3053 is a fabG Mutation 
To identify the effects of calcium agonists on E. coli, Holland and coworkers. 54 isolated a TFP 
resistant mutant strain (OMG3053) that showed reduced growth at 42°C. This mutation, tfpA1, 
was reported to map in the fabD gene by complementation analysis using a genome fragment 
encoding the fabD, fabG and acpP genes of the E. coli FAS gene cluster. However, since no details 
were available as to the exact nature of the mutation, we amplified and sequenced a 2500 bp 
genomic region of strain OMG3053 (Primers FA F1 through FA R5), extending from within fabH 
to fabF. This allowed us to identify the tfpA1 mutation as a 24 bp in-frame deletion (∆598-621) 
within the fabG gene (Fig. 3.1A) with no changes to the rest of the FAS operon including fabD. 
The eight amino acid residues, ILAQVPAG (residues 200-207), are part of the ⍺7 helix and the 
loop connecting ⍺7 to helix ⍺8.  
 
Strain OMG3053 was isolated from an ill-defined parent strain (D22) having a mutation (envA1 
now lpxC101) that makes the cells hyperpermeable to both hydrophilic and lipophilic agents 
including TFP 53. In order to study the tfpA1 mutation in isolation, we reconstructed this deletion 
in the wild type E. coli strain MC1061 using a CRISPR-Cas9 system to produce strain SW01and 
renamed the mutation as fabG∆8. 
 
3.3.2 Phenotype of the fabG∆8 Mutation   
The growth rate of the fabG∆8 mutant strain SW01in LB medium was decreased even at the 
permissive temperature of 25°C, with the doubling time increased to 90 min versus 60 min for the 
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parental strain. Growth was drastically decreased at temperatures above 30°C. However, fabG∆8 
continues to grow for several hours, albeit very poorly, at 42°C suggesting that the cell continues 
to be viable even at this temperature (Fig. 3.1B). However, when grown overnight on solid media, 
minute colonies of the fabG∆8 strain form at 42°C. When these plates were returned to 25°C, 
growth was restored, suggesting that the cells remain viable at the non-permissive temperature. 
Overexpression of the mutant protein (using plasmid pSW01) in the mutant strain gave only a 
minor improvement in doubling time (data not shown).    
 
The fabG∆8 mutation was readily complemented for restoration of growth at 42°C by a plasmid-
borne wild type copy of fabG (pSW02). Structural modeling of the mutant protein against the wild 
type E. coli FabG indicated a severe disordering of the ⍺6-⍺7 subdomain with a potential loss of 
interaction at a cleft formed by the end of ß6’ and ⍺5’ (primes indicating neighboring monomers 
in the tetramer) (Fig. 3.1C). Surprisingly, fabG∆8 (pSW01) complemented the temperature-
sensitive phenotype of CL104 (Fig. 3.2A), another E. coli fabG(Ts) strain that has a point mutation 
elsewhere in the gene. A possible explanation is that mixed dimers are formed between the two 
mutant proteins that compensate for one another resulting in proteins that are sufficiently stable to 
support growth at 42°C. Since, overexpression of fabG∆8 from a plasmid (pSW01) in MG1655 
has no observable phenotype at 25°C or 42°C, the mutation is recessive (Fig. 3.2B) suggesting that 
if mixed dimers are formed between the mutant and wild type monomers, these proteins are 
functional.  
  
At 25°C, unlike its mucoid lpxC parent, the colony morphology of strains OMG3053 and SW01 
on LB agar were normal.  As previously reported, the Ts mutation of strain OMG3053 confers 
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resistance to 50 µg/ml TFP in the D22 background (Fig. 3.2C). However, upon prolonged 
incubation strain OMG3053 colonies become mucoid like the parental strain D22 whereas strain 
SW01 retains normal colony morphology. Unexpectedly, strain SW01 gave revertants that grew 
reliably at 42°C. Revertants were isolated at a frequency of about 10-8. The fatty acid operons of 
sixteen revertants were sequenced with twelve identified as intragenic suppressors in fabG (M96V 
or E185D). The eight-residue deletion remained unaltered. Met96 is located at the end of helix ⍺4 
at the ⍺4-⍺4’ dimer interface whereas Glu185 is located at the mouth of the active-site tunnel in 
proximity to ⍺6. The other suppressors are in locations other than the fatty acid operon and are yet 
to be identified.  One possibility is that these suppressors increase the levels of chaperone proteins 
which can stabilize mutant proteins 61,62. 
 
3.3.3 In vitro β-ketoacyl-ACP Reductase Activity/Calcium Sensitivity 
The reductase activity of FabG is readily detected spectrophotometrically by monitoring the 
oxidation of the NADPH cofactor at 340 nm 43.  Although wild type FabG can reduce acetoacetyl-
CoA using NADPH, FabG∆8 showed no activity towards CoA-thioester substrates (Fig. 3A).  
Note that the FabG acetoacetyl-CoA reductase activity is not inhibited by TFP indicating that the 
action of TFP is indirect.  To characterize the activity of FabG∆8 in vitro using its physiologically-
relevant acyl-ACP substrates, a reconstituted fatty acid synthesis system was utilized (Fig. 3.3B). 
Due to its instability, malonyl-ACP was generated in the reaction using purified E. coli FabD and 
then converted to acetoacetyl-ACP using E. coli FabH and acetyl-CoA. For product stability and 
to obtain sufficient separation on conformation-sensitive gels, the product of the FabG reduction 
was further dehydrated and reduced to butyryl-ACP using E. coli FabA and FabI.  At 25°C, both 
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FabG∆8 and FabG can catalyze reduction of the acetoacetyl-ACP, whereas at 42°C, FabG∆8 is 
inactive. (Fig. 3.3C) 
 
Price and coworkers63 have shown that E. coli FabG is sensitive to the presence of divalent cations 
of calcium and magnesium, with monovalent cations of sodium having no effect on activity. Their 
structural data seems to suggest that these cations might block in vitro activity by occluding access 
to active site. One of the calcium binding sites in the tetramer is formed between the Gln203 
located in the ⍺6/⍺7 subdomain and the oxygen of Asn145 63. The lack of the ⍺6/⍺7 subdomain in 
FabG∆8 which includes Gln203 results in a 100-fold increase in the sensitivity of FabG∆8 to the 
presence of calcium at 25°C. The β-ketoacyl-ACP reductase activity of FabG∆8 was significantly 
inhibited by100 µM calcium whereas inhibition of the wild type FabG required 10 mM calcium 
under the same conditions. Monovalent sodium cations had no observable effect (data not shown) 
as expected from prior work 63.   
 
3.3.4 The FabG∆8 protein is Deficient in Dimer Formation at 42°C 
The absence of part of the ⍺6/⍺7 subdomain suggested that the dimerization ability of the mutant 
protein should be compromised. A C-terminal hexahistidine-tagged version of FabG∆8 protein 
was overexpressed in the fabG∆8 mutant background (SW01) strain at 25°C using a helper plasmid 
that produced T7 RNA polymerase. The hexahistidine-tagged wild type E. coli FabG protein is 
readily over-expressed, in soluble form and readily purified using routine Ni-NTA based 
methods63. The FabG∆8 protein, like the proteins encoded by other fabG(Ts) strains49 was difficult 
to purify in an active form and was very labile. Indeed, earlier work on other fabG(Ts) strains was 
limited to assaying enzyme activities in cell free extracts due to the extreme lability of the mutant 
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enzymes.  We purified the FabG∆8 to homogeneity using Ni-NTA affinity chromatography and 
the protein was immediately dialyzed to remove the eluting imidazole, concentrated 10-fold and 
stored at -80°C. Handling time was minimized at the expense of protein recovery to facilitate 
retention of activity. The wild type FabG was purified similarly from the parental strain (MC1061). 
SDS-PAGE analysis showed that the mutant protein migrated with an apparent molecular weight 
of 25 kDa (Fig. 3.4A) whereas the wild type protein migrated with an apparent molecular weight 
of 27 kDa. Size exclusion chromatography of the purified FabG∆8 protein indicated that in its 
solution form ~52% of the total protein was monomeric (apparent molecular mass of 23 kDa) with 
only ~27% present as a tetramer (92 kDa). About 21% of the protein was observed in an aggregated 
form. The wild type protein, however, was predominantly dimeric (~99%) with an apparent 
molecular mass of 48 kDa (Fig. 4B) with ~1% aggregation. This indicates that the mutant has 
impaired interactions that prevent it from undergoing the first dimerization event whereas the 
second dimerization event that forms the tetramer proceeds well.  It seems likely that in the small 
fraction of the mutant protein that manage to form the first dimer, the second dimerization event 
has a compensating effect that stabilizes the tetrameric structure.  To test the effects of temperature, 
the purified proteins were incubated at 25°C and 42°C for 30 min and then cross-linked using 
varying amounts of a chemical crosslinking agent. The crosslinking reactions were quenched and 
analyzed by SDS-PAGE. Although the mutant protein, like the wild type FabG protein, showed 
dimerization and tetramerization at 25°C, the mutant required a 10-fold higher concentration of 
crosslinker to produce a visible a dimer band, indicating a significant dimerization deficiency at 
42°C, although tetramer formation remained unimpaired at this temperature. Of note, the wild type 
protein has a more prominent dimer band than its tetramer band even at higher concentrations of 




These data, in combination with structural information about the monomer-monomer interaction 
interfaces, offers a glimpse in the mechanism of FabG tetramerization. These data suggest that in 
the intact protein the most stable and probably the first interaction occurs between the ß7 strands 
with some interactions involving the ⍺6/⍺7 subdomain. The second dimerization at the ⍺4/⍺4’ and 
⍺5/⍺5’ dimer interface to form the tetrameric form further stabilizes the structure. The FabG∆8 
protein is impaired at the first dimerization stage and thus either remains as an inactive monomer 
or requires the additional stabilizing interactions given by tetramerization to form a functional 
protein.  
 
3.3.5 The fabG∆8 strain SW01 is Defective in Phospholipid Synthesis at the Non-permissive 
Temperature and Shows Altered Fatty Acid Composition  
In bacteria, a majority of the fatty acids produced in the cell are used for the synthesis and 
maintenance of the phospholipid bilayers and the lipid A component of the lipopolysaccharide. To 
identify the reason for the reduced growth of the fabG∆8 mutant at 25°C and the growth deficiency 
at 42°C, cultures were grown to mid log phase at the permissive temperatures and then shifted to 
42°C for 2 h. 14C-Acetate was added to the cultures which were growth for an additional 2 h. The 
cultures were normalized by optical density measurements at 600 nm and cellular phospholipids 
were then extracted and separated by thin layer chromatography and visualized by 
autoradiography. The levels of fatty acid synthesis in vivo after the temperature upshift could then 
be quantitated by measuring the radiolabel incorporated into the phospholipid fraction. The mutant 
retained only 30% of the fatty acid synthetic ability of the wild type strain (Fig. 3.5A). The loss of 
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synthesis was successfully complemented by introduction of a wild type copy of fabG on plasmid 
pSW02 into the mutant strain.  
 
The composition of fatty acids species in the fabG∆8 mutant strain SW01 grown at 25°C was 
measured by in-source collision induced electrospray ionization dissociation of the phospholipid 
samples.  The data showed that relative to the wild type strain, MC1061, the levels of the C18:1 
fatty acid decreased by 60% whereas C16:0 decreased by 25-30% in the mutant relative to the 
major C16:1 peak in comparison to the wild type strain (Fig. 3.5B).  Electrospray ionization 
analysis of the molecular species of phosphatidylglycerol gave similar results with a shift to 
species having shorter acyl chains (data not shown) as expected from reduced flux through the 
fatty acid synthesis cycle.  
 
3.3.6 The fabG∆8 Mutation Alters the Lipid A Fatty Acid Composition but Only in the 
lpxC101 Background 
The acylated lipid A core is an essential component of the Gram-negative cell wall that anchors 
the lipopolysaccharide backbone to the outer membrane. Lipid A was isolated and analyzed by 
MALDI-MS using a gentle SDS based method 64,65. In agreement with previous reports for wild 
type E. coli, a major peak at m/z 1797.16 corresponding to a hexa-acylated diphosphorylated lipid 
A (Figs. 3.6A and 6B) containing four C14:0 3-hydroxy chains and one C12:0 chain. Other minor 
peaks centered at m/z 1768.13 and m/z 1824.20 correspond to a loss/gain of a hydroxyl group, 
whereas those centered at m/z 1716.16 correspond to a loss of a phosphate group. In combination 
with the lpxC101 mutation, the fabG∆8 strain (OMG3053) produced a remarkably different set of 
lipid A species. The negative mass spectrum was dominated by four sets of peaks centered at m/z 
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1445.87, m/z 1615.98, m/z 1797.16 and m/z 1852.17. The peak at m/z 1615.98 was assigned to 
hexa-acylated diphosphorylated lipid A species having two C10:0 3-hydroxy chains, three C12:0, 
2 (or 3-OH C12:0 chains) and one C12:0 chain (Figs. 3.6A and 6D). The peaks centered at m/z 
1445.87 correspond to the loss of one C10:0 3-hydroxy acyl chain (Δmass of 170) whereas those at 
m/z 1852.17 correspond to the gain of one C16:0 acyl chain (Δmass of 236). Strain D22 (lpxC101) 
retained a wild type lipid A composition (Fig. 3.6C). Remarkably, strain MC1061 derived fabG∆8 
strain SW01, had a wild type lipid A acyl chain composition suggesting that a tight regulatory 
network exists between FAS and lipid A synthesis that maintains structural integrity of the cell, 




In this chapter, I delineate the biochemical properties of a E. coli fabG(Ts) mutant strain and its 
phenotypic effects on growth. Unlike typical temperature-sensitive phenotypes caused by point 
mutations, the fabG∆8 strain lacks eight residues that form a part of the ⍺7 helix and the loop 
connecting ⍺7 to the ⍺8 helix in the ⍺6/⍺7 subdomain. This subdomain is responsible for active-
site tunnel formation and for dimerization 47.  
 
My data shows that FabG∆8 cannot efficiently form dimers, probably due to weakened monomer-
monomer interactions at the dimer interface that involve the ⍺6/⍺7 subdomain and Tyr129’ that is 
further exacerbated by an increase in temperature and leads to significant reduction in enzyme 
activity. Although E. coli FabG crystallized as a tetramer, to my knowledge the only measurements 
of the solution structure of a ß-ketoacyl-ACP reductase were done on a plant enzyme 66.   
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Using exclusion chromatography, I show that the protein predominantly exists as a dimer in 
solution. This is further validated by the more prominent dimer band in my crosslinking 
experiments. The mutant protein, however, exists either as a monomer or a tetramer. Since, the 
FabG tetramer is well described as a dimer of dimers 47, my data suggests that the initial 
dimerization event is the limiting step in assembly of the mutant tetramer.  
 
Interestingly, the altered interface also appears to play an important role in NADP(H)-induced 
allostery63. In the mutant protein, the additional interactions resulting from the second dimerization 
(dimerization of two dimers) seem to act to stabilize the protein in the active tetrameric form. 
Unexpectedly, the deletion mutant reverts at a frequency reminiscent of a point mutant. One of the 
suppressor mutations (M96V) maps to the second dimerization interface. The interaction at this 
interface is mainly hydrophobic with one of the suppressors replacing a methionine side chain with 
a differently shaped and somewhat more hydrophobic valine side chain. M96 participates in an 
important hydrogen bonding interaction with Glu168’ which plays a role in the allosteric behavior 
of FabG. This bonding probably increases the interaction between the dimers offering sufficient 
stabilization at higher temperatures to restore function.  
 
The second intragenic suppressor observed (E185D) is at the base of the ⍺6/⍺7 subdomain. 
Substituting glutamate with the shorter aspartate might serve to rein in the ⍺6 domain by 
interaction with Arg190 to give increased order of the interface. Also, since the mutant strain 
retains the ability to grow very slowly at 42°C, a small fraction of the monomers probably interacts 
long enough to form active tetramers that catalyze the residual growth of the mutant strain.  It 
should be noted that there is no a priori reason (such active sites formed by an interface) for FabG 
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to be a tetramer.  Indeed, a dimeric ß-ketoacyl-ACP reductase is encoded by Synechocystis 67 and 
the solution structure of Pseudomonas aeruginosa RhlG, a ß-ketoacyl-ACP reductase essential for 
rhamnolipid synthesis, has been reported to be dimeric by both size exclusion chromatography and 
analytical ultracentrifugation, although at high protein concentrations tetramers were observed 68. 
 
Although the mutant strain OMG3053 originally isolated by Holland et al. 54, was reported to a 
fabD mutation that conferred TFP resistance to an lpxC strain, the report was in error. This report 
is puzzling in that, although the investigators sequenced a subclone derived from the original 
complementing plasmid that carried the wild type sequence, they did not report the sequence of 
the mutant gene. Moreover, a plasmid carrying the entire fabD gene together with upstream (fabH) 
and downstream (fabG) sequences failed to restore growth at 42ºC although transcription should 
have been driven by the vector tetracycline promoter 54.  A plasmid encoding fabG also failed to 
complement, however that gene lacked a promoter.  The fabG gene was encoded on the strand 
opposite the tetracycline promoter and later work showed that the cloned fragment does not contain 
a promoter 48.  Indeed, the authors concluded that it “has not been unequivocally demonstrated that 
tfpA1 mutant carries a single mutation in fabD”. 
 
LpxC catalyzes an irreversible deacetylation step during lipid A synthesis. The lpxC101 mutation 
results in sensitivity to TFP in addition to other agents like detergents. Moreover, strain D22 has a 
very abnormal, mucoid and slimy colony morphology. Since lpxC101 mutants show marked outer 
membrane defects, we constructed the fabG∆8 mutation in a wild type strain using a markerless 
CRISPR-Cas9 based methodology. Although both lpxC101(D22) and fabG∆8 (SW01) have 
growth defects, they have normal lipid A compositions. Remarkably, strain OMG3053 has a very 
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unusual lipid A composition that has C10 and C12 chains in place of C14 chains to give 
composition that is reminiscent of Pseudomonas aeruginosa lipid A 69. It is known that E. coli can 
tolerate a similar shortening of the lipid A acyl chains 70.  In vitro, TFP has no effect on the activity 
of FabG measured spectrophotometrically using acetoacetyl-CoA as a substrate, suggesting that 
TFP does not directly affect FabG.  Earlier studies have identified E. coli suppressors in fabZ that 
compensate for the presence of LpxC inhibitors and restore cellular homeostasis 71. This has been 
attributed to the fact that since both fabZ and lpxD (which produces the LpxC substrate) compete 
for the same ß-hydroxymyristoyl-ACP substrate pool, a compensating mutation in fabZ would lead 
to a balanced growth in a lpxC mutant. However, suppressor mutations in E. coli fabG were not 
reported. Surprisingly, in P. aeruginosa similar LpxC inhibitor studies gave, mutations in fabG 72.  
It should be noted that FabG and FabZ catalyze consecutive steps in the fatty acid synthesis cycle 
and both reactions are freely reversible. Hence, interplay between the two enzyme activities does 
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Strains Relevant Genotype Source 
MC1061 Wild type strain Casadaban, et 
al., 1980 




MG1655 K-12 F– λ– ilvG– rfb-50 rph-1 CGSC #6300 
BL21 (Star) ompT hsdSB (rB-, mB-) gal dcm rne131 (DE3) Invitrogen 
D21 proA23, lac-28, tsx-81, trp-30, his-51, rpsL173 ampCp-1 Boman, et al., 
1968 
D22 As D21, lpxC101 Normark, et 
al., 1969 
OMG3053 As D22, tfpA1 Bouquin, et 
al., 1995 
CL104 MG1655 fabG(Ts) panD::Cm Lai, et al., 
2004 
SW01 MC1061 fabG∆8 (Ts) This work 
 




Plasmids Relevant Characteristics Source 
pBAD24 AmpR, Arabinose-inducible expression vector Guzman, et 
al., 1995 
pET28a KanR, T7 promoter-based, IPTG inducible expression 
vector 
Novagen 
pCY560 SpcR, Arabinose-inducible expression of T7 Polymerase;  Hassan, et al., 
2011 
pSW01 AmpR, PCR-amplified fabG∆8(Ts) gene from SW01 in 
Nco1/SphI sites of pBAD24 
This work 
pSW02 AmpR, PCR-amplified wild-type fabG gene from MC1061 
in NcoI/SphI sites of pBAD24 
This work 
pSW03 KanR, PCR-amplified fabG∆8(Ts) gene from SW01 in 
BamHI/XhoI sites of pET28a 
This work 
pSW04 KanR, PCR-amplified wild-type fabG gene from MC1061 
in BamHI/XhoI sites of pET28a 
This work 
pSW05 KanR, PCR-amplified fabD gene from MG1655 in 
BamHI/XhoI sites of pET28a 
This work 
pSW06 KanR, PCR-amplified fabH gene from MG1655 in 
BamHI/XhoI sites of pET28a 
This work 
pSW07 KanR, PCR-amplified fabA gene from MG1655 in 
BamHI/XhoI sites of pET28a 
This work 
pSW08 KanR, PCR-amplified fabI gene from MG1655 in 
BamHI/XhoI sites of pET28a 
This work 
pCRISPR KanR, crRNA expression plasmid Jiang et. al., 
2013 
pCRISPR KanR, fabD crRNA inserted in Bsa1 sites This work 
pCas9 CmR, Streptococcus pyogenes Cas9 nuclease and 
tracrRNA under their native promoters 
Jiang et. al., 
2013 










fabG BspH1 F ATGCATTCATGAATTTTGAAGGAAAAATCGC 
fabG Sph1 R ATGCATGCATGCTCAGACCATGTACATCCCGC 
fabG BamH1 F ATGCAT GGATCC ATGAATTTTGAAGGAAAAATCGC 
fabG Xho1 R ATGCATCTCGAGTCAGACCATGTACATCCCGC 
FA F1 GATCGCCACGGTAATACCTC 
FA F2 TGCGTCTGGTTGAGATGC 
FA F3 GCTTACTGGCCTGACGAAAC 
FA F4 CACTATCGGTTCTGTGGTTGG 
FA F5 CTACGAAAACCATCGCGAAA 
FA R1 CTTTCGCAATAGACGCATCA 
FA R2 CTTTTAAAGCTCGAGCGCC 
FA R3 TTACTGAAGCCGATCAAGCC 
FA R4 CAGCTGTTCGCCGATAATTT 
FA R5 AATGAAGGCATCCATCTTGC 
CR fabG S AAAC TATCCTGGCGCAGGTTCCTG G 




















Figure 3.1 The E. coli fabG∆8 encoded protein lacks eight amino acid resides and confers 
temperature sensitivity and trifluoperazine resistance. A) Sequence alignment of bases 566 to 
625 of fabG from strain MC1061 and the fabG∆8 strain SW01. Missing bases are indicated by ‘#’. 
Helices ⍺6 and ⍺7 and the turn (indicated by a series of ‘T’s) are shown above the amino acid 
sequence B) Growth of mutant E. coli strain fabG∆8 (SW01) at 30ºC or 42ºC. The control strains 
were the wild type MC1061, strain SW01 with either an empty pBAD24 vector or this vector 
bearing the wild type E. coli fabG (pSW02) C) Structural model of FabG∆8 (green) generated by 
SWISS-MODEL aligned with a monomer of wild type FabG (red) (PDB:1I01). A space-filling 
model of a second monomer is shown to highlight monomer-monomer interactions missing in 










Figure 3.2 Expression of fabG∆8 complements growth of the E. coli fabG(Ts) strain CL104 
at 42ºC, fabG∆8 is recessive to wild type fabG and causes resistance to TFP in an lpxC101 
background. A) CL104 is an E. coli fabG(Ts) strain carrying a E233K point mutation49 . FabG∆8 
was expressed from a pBAD24-derived plasmid from an arabinose inducible promoter. The control 
strains are CL104 containing the empty vector (pBAD24) or pBAD24 expressing wild type E. coli 
fabG (pSW02). Complementation proceeded both in the presence and absence of arabinose. B) 
Expression of the mutant FabG (pSW01) does not effect growth of the wild type E. coli strain 
MG1655 at 25ºC or 42ºC. FabG∆8 was expressed from a pBAD24-derived plasmid under an 
arabinose inducible promoter. The control strain is strain MG1655 containing an empty vector 
(pBAD24). Growth was observed both in the presence and absence of arabinose. All plates 
contained arabinose. C) Growth of mutant E. coli strain OMG3053 in the presence and absence of 






Figure 3.3 FabG∆8 loses ß-ketoacyl-ACP reductase activity at higher temperatures and in 
the presence of calcium. A) Oxidation of the NADPH cofactor was monitored 
spectrophotometrically at 340 nm for 120 seconds. Symbols ▲: FabG (0.1 µg) ⚫: FabGΔ8 (0.1 
µg) ⬥: FabGΔ8 (1 µg) ⨯: FabG + TFP B) Schematic diagram of the enzymatic reaction system 
used to test ß-ketoacyl-ACP reductase activity. C) Enzymatic assays for FabG∆8 catalyzed 
reduction of acetoacetyl-ACP to hydroxyl butyryl-ACP. The enzymatic reactions (40 μl) were 
performed at 25°C, 37°C or 42°C and contained holo-ACP converted to acetoacetyl-ACP by the 
action of E. coli FabD (plus malonyl-CoA) and FabH (plus acetyl-CoA). The product is dehydrated 
(FabA) and then reduced (FabI) to the faster-migrating butyryl-ACP, which can be resolved from 
the substrate in a destabilizing urea-PAGE system (Materials and Methods). FabG∆8 was tested 
at two levels (2 μg and 10 μg) at 25°C and 42°C and at 3 levels (2 μg, 5 μg and 10 μg) at 37°C.  
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Figure 3.3 (cont.) 
The no enzyme controls contained all components except FabG or FabG∆8. D) Effects of calcium 
on FabG∆8 reductase activity in vitro. ‘C’ denotes no addition of FabG/FabG∆8 whereas the 
triangle represents an CaCl2 dilution series (0, 0.1, 1, 10 mM). Reactions are performed as above. 
Lanes 2-5 had 2 μg of FabG added per reaction (40 μl) whereas lanes 6-9 had 10 μg of FabG∆8 





Figure 3.4 FabG∆8 is deficient in dimerization. A) Purification of C-terminally His6-tagged 
FabG∆8 protein and analysis by SDS-PAGE. Lane 2: Extract of the FabG∆8 overexpression strain; 
Lanes 3-8: Serial elution with 50-500 mM Imidazole; Lane 7: Purified FabG∆8 protein. B) Size 
exclusion chromatographic elution profile of purified hexahistidine-tagged FabG∆8 (in black). 
This is overlaid with a similar profile from purified hexahistidine-tagged wild type FabG (in grey), 
with the estimated molecular masses and their solution structure indicated next to each peak. C) 
The solution structures of the proteins were determined by comparison to the elution patterns of a 
series of standards (Bio-Rad) and Blue Dextran. The standards were vitamin B12 (1.35 kDa), 
myoglobin (horse, 17 kDa), ovalbumin (chicken, 44 kDa), γ-globulin (bovine, 158 kDa). The 
elution position of each of the standard peaks gave an estimated molecular mass marked on the 
profile based on graphic analysis of the standard curve. Kav, partition coefficient. MW, molecular 
weight. D) Chemical crosslinking of FabG and FabG∆8 proteins with increasing amounts of 
ethylene glycol bis[succinimidylsuccinate] (EGS) (0 to 5 mM). Left panel:  Incubated at 25°C for 
15 min followed by crosslinking for 30 min at 25°C Right Panel: Incubated at 42°C for 15 min 







Figure 3.5 Changes in the synthesis and composition of phospholipid fatty acids 
synthesized by the fabG∆8 SW01strain. A) Autoradiograph of radiolabeled phospholipids 
separated on a silica G-thin layer chromatography plate. Phospholipids were labelled using 
[14C]acetate added to the growth medium after shift from 25°C to 42°C. Strains MC1061 and 
SW01 complemented with wild type fabG (pSW02) served as controls The amounts of 
phospholipids produced relative to the wild type MC1061strain at 42°C were 30% for strain 
SW01 and 116% for strain SW01 carrying the FabG wild type expression plasmid pSW02. 
The radiolabeled thin layer chromatography spots were quantified with a GE Typhoon 
FLA7000 phosphorimager using the Image Quant TL software and all values are the average 
of two experiments. B) Electrospray ionization mass spectrometry of phospholipid extracts of 
the wild type strain MC1061 (left panel) and the fabG∆8 SW01 strain (right panel) grown at 




Figure 3.6 Lipid A composition of the mutant in an lpxC background. A) Predicted structures 
of the major lipid A species observed, with chain length indicated below each acyl chain. B) 
Negative ion mode MALDI-TOF spectra of lipid A extracts from D21 (wildtype) C) D22 
(lpxC101) D) OMG3053 (lpxC101 fabG∆8). (P: phosphoryl group; OH: hydroxyl group; Na: 










The ability to make sophisticated and precise genome modifications in a reasonable timescale has 
made Escherichia coli one of the most comprehensively studied and understood genomes of any 
organism. Most of the first available genome engineering tools in E. coli rely on either a phage-
derived homologous recombination (HR) pathway [4-6] or group-II intron-based homing [7] for 
targeted gene editing. Recombinogenic methods based on the λ-phage proteins Exo, Beta and 
Gamma (λ Red)[8] catalyze allelic exchange with just 35 bp of homology but typically utilize an 
antibiotic selection marker and leave a “scar” behind . Achieving scar-less manipulation usually 
requires a counter-selectable marker or multiple rounds of recombination. Despite the successful 
application of these techniques, modification of genes that are either themselves essential or are 
part of an operon with downstream essential genes remains challenging. Most of the current tools 
either require expression of the gene(s) in trans or a more complex cloning strategy to restore 
disrupted codons/promoters.  
 
One of the most recent breakthroughs has been the development of a novel RNA-guided 
endonuclease-based genome editing system called the clustered regularly interspaced short 
palindromic repeat (CRISPR)/CRISPR associated Streptocccus pyogenes (Sp) protein 9 system 
(Cas9). A CRISPR RNA (crRNA) forms an RNA duplex with a trans-acting crRNA (tracrRNA), 
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which then helps recruit the Cas9 endonuclease to target a 20 bp protospacer on the genome which 
matches the sequence of the crRNA and is immediately adjacent to a Cas9 specific protospacer 
adjacent motif (PAM). Later studies demonstrated that the tracrRNA:crRNA duplex can be 
replaced with a single guide RNA (sgRNA). Thus, by simply changing the 20 bp sequence within 
a plasmid-encoded sgRNA, one can reprogram the target of the Cas9 endonuclease. The DSBs 
resulting from CRISPR action are lethal to E. coli because it lacks a non-homologous end joining 
mechanism (NHEJ).  
 
The CRISPR/Cas9 system using crRNA expressed from a plasmid has been shown to successfully 
incorporate point mutations in the rpsL gene in E. coli in the presence of λ-Red with an efficiency 
of 60%. Early varieties of the CRISPR/Cas9 tools in E. coli provided SpCas9 and its tracrRNA 
under its native promoter on one plasmid and a crRNA in a separate high copy number plasmid, 
with a requirement for the presence of the λred genes on a third plasmid or on the chromosome. 
Later iterations have used sgRNA for ease of cloning and combined λ -Red with either the Cas9 
gene or the sgRNA.  
 
Curing these plasmids after accomplishing the desired changes often requires multiple rounds of 
growth in selection-free media followed by a screening for plasmid loss. Other two-plasmid 
systems typically utilize a pSC101(Ts) backbone for the sgRNA plasmid to permit easier curing. 





In this Chapter, I describe the construction of a set of compatible vectors which can only replicate 
in the presence of IPTG. Using one of these vectors, a CRISPR-Cas9 system was assembled that 
can be used to make rapid iterative changes with ease while leaving a plasmid-free modified strain. 
 
4.2 MATERIALS AND METHODS 
 
4.2.1 Bacterial Strains, Plasmids and Growth Conditions  
E. coli strain BW25113 was employed for genome editing and DH5α for cloning. Lambda Red 
recombineering donor plasmid pKD46 was obtained from the E. coli Genetic Stock Center at Yale 
University. pCas9-CR4 and pKDsgRNA-p15a were a gift from Kristala Prather (Addgene 
plasmids # 62655 and 62656). Oligonucleotides were synthesized by Integrated DNA 
Technologies (IDT) at the 25 μg scale using standard desalting. E. coli strains were grown 
aerobically in shake flask cultures at 37˚C and 250 rpm in lysogeny broth (LB) unless stated 
otherwise. Recombinant strains were selected with 100 µg/ml ampicillin or 10 µg/ml 
chloramphenicol and stored in 40% glycerol at -80˚C. 
 
4.2.2 Construction of the pI Vector Series 
The p15a origin was amplified from vector pACYC184 by PCR using primers p15a KpnI F and 
p15a XbaI R while the RSF1030 and RSF1031 origins were amplified by PCR from pCY2016 and 
pCY2017 using primers RSF KpnI F and RSF XbaI R. RSF1030 and RSF1031 differ from one 
other by a single nucleotide. The primers contain restriction sites for KpnI and XbaI, respectively. 
The respective fragments and pAM34 were digested with KpnI plus XbaI and ligated to obtain 
plasmids pI15, pI1030 and pI1031, respectively. Antibiotic resistance markers for 
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chloramphenicol, kanamycin and gentamycin were amplified from p34-C, p34-K and p34-G by 
PCR using the primers p34C AatII F/ p34C Xba1 R, p34K AatII F/ p34K XbaI R and p34G AatII 
F/ p34G XbaI R, respectively. The resultant fragments were digested with AatII/Xba1 and ligated 
to a pAM34 fragment digested with the same restriction enzymes. For consistency, the resultant 
plasmids were named pIBRC, pIBRK and pIBRG.  
 
4.2.3 Determination of Copy Numbers and Rates of Curing 
Copy number determinations were made by growing cultures in LB to an OD of 1.0 and extracting 
plasmids from 1 ml of culture. The extracted plasmids were digested with XbaI and run on a 1% 
agarose gel. DNA amounts were estimated by densitometry calculations on a Biorad Chemidoc 
XRS.  
 
To measure the rate of curing of plasmids pAM34, pI15, pI1030 and pI1031, strains carrying the 
plasmids were first grown in a selection-free LB medium and then periodically plated on LB agar 
containing IPTG. Optical density measurements were also made at this time to calculate the 
number of generations that occurred since selection pressure was removed. Cultures were again 
diluted when an OD of 1.2 was reached until 25 generations had elapsed. Thirty six colonies were 
screened per plasmid, at each timepoint, for resistance to ampicillin.  
 
4.2.4 Construction of pITRCas9 and pSgRNA 
A fragment containing lacIQ and part of the p15a origin was amplified by PCR from pI15 using 
primer p15a-lacI SpeI F and p15a-lacI AgeI R. pCas9-CR4 and the PCR fragment were digested 
with SpeI plus AgeI and ligated to give pSW09. λred genes under arabinose control were amplified 
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from pKD46 using primers LRed AatII F and LRed term AatII R. A minimal dual direction tonB 
terminator was introduced with sequence 5’-CATGGTAATAGTCAAAAGCCTCCGGTCGGAG 
GCTTTTGACTTAAGCTT-3’. This fragment was digested with AatII and ligated with pSW09 
digested with the same enzyme. The resultant plasmid was named pITRCas9. Correct assembly 
was confirmed by restriction digestion and by PCR amplification of the junctions. 
 
To construct pSgRNA, pKDSgRNA-p15a and an ampicillin resistance fragment amplified from 
pKD46 (primers Amp NcoI F and Amp XhoI R) were digested with NcoI plus XhoI and ligated to 
give pSW10. This removed the plasmid encoding the λred genes and spectinomycin resistance 
fragment. The resulting plasmid was linearized by PCR using primers Non Ts F and Non Ts R 
while introducing a point mutation (A to G) that restores temperature independent growth. The 
linear fragment was phosphorylated using NEB T4 polynucleotide kinase and self-ligated to give 
pSW11. This was digested with NcoI and ligated with a synthetic construct containing an E. coli 
codon optimized Photorhabdus luminescens rpsL gene under a constitutive proD promoter. The 
20 bp protospacer region of the resulting plasmid pSgRNA-p15a, was modified to contain a NcoI 
site flanked by two BbsI sites by PCR using the strategy described below to yield pSgRNA.  
 
4.2.5 Protospacer Cloning into pSgRNA 
All pSgRNA-xxx plasmids (where xxx denotes the gene targeted) were created using a one-step 
digestion-free PCR based cloning (DFPC) strategy as described below. The entire pSgRNA 
plasmid was amplified via PCR using a target specific primer pSgRNA-xxx F, a fixed primer 
pSgRNA-R and pSgRNA as template to yield a linear product. A 15 cycle PCR was performed 
using Q5 polymerase, using an annealing temperature of 59°C and an extension time of 45 seconds 
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with the remaining steps as per the manufacturer protocol. The amplified DNA was then purified 
using a Qiagen PCR purification kit and DNA concentration was measured using a Nanodrop 
spectrophotometer. The phosphorylation reaction was composed of 100 ng of purified linear DNA, 
adjusted to 10 µl using water, combined with 10 µl of 2X Quick Ligation buffer (NEB) and 1 µl 
of T4 polynucleotide kinase (NEB). This was allowed to incubate at 37°C for 30 mins and then 
cooled to room temperature for 5 mins. One µl of NEB Quick Ligase was then added and the 
reaction allowed to incubate at 25°C for another 15-30 min. Two µl of this reaction mixture was 
used to transform 50 µl of chemically competent E. coli DH5α or NEB Turbo cells and selected 
on plates with 100 µg/ml ampicillin.  
 
Successful integration of the 20 bp protospacer sequence would replace one of three NcoI sites 
and thus can be first verified via restriction digestion and subsequently by sequencing using Primer 
set pSgRNA check.   
 
4.2.6 Homologous Recombination 
E. coli strain SW02 carrying plasmid pIRTCas9 was first transformed with plasmid pSgRNA-xxx 
by electroporation and selected for growth on chloramphenicol, ampicillin and IPTG containing 
plates. Large colonies were selected and grown at 37°C in LB medium supplemented with 
chloroamphenicol, IPTG and ampicillin to an optical density of 0.4 and λred gene expression was 
induced by the addition of 0.4% arabinose for 30 minutes. Cells were harvested by centrifugation 
and then washed thrice with ice-cold 10% glycerol solutions. The cells were then resuspended in 




Donor oligonucleotides were added to 50 µl of cells at a final concentration of 10 µM and 
transferred to a 0.1 cm electroporation cuvette. Electroporation was performed on a BioRad Gene 
Pulser and cells were immediately recovered in 1 mL final volume of SOB with 1 mM IPTG for 
45 min at 37ºC before plating on LB with 100 µg/ml anhydrotetracycline. Plates were incubated 
overnight at 37 °C or 30 °C for Ts strains. A small portion of the recovered cells were plated on 
LB as a control for transformation efficiency. 
 
4.2.7 Plasmid Curing 
The pSgRNA plasmid can be cured when manipulations are performed in a streptomycin resistant 
background. Strains were first grown in liquid culture and then subsequently plated on solid media, 
both supplemented with 300 µg/ml of streptomycin. Loss of the plasmid was verified by loss of 
ampicillin resistance. pITRCas9 is cured by growing in IPTG-free media for 10 or more doublings. 
Both plasmids can be cured simultaneously by growth in media containing streptomycin and 
lacking IPTG.  
 
4.2.8 Efficiency of editing 
The efficiency of the CRISPR/Cas9 system under different conditions is expressed as the ratio of 
the number of surviving cells in the absence and presence of anhydrotetracycline. All colony 







4.3 EXPERIMENTAL RESULTS 
 
4.3.1 Alignment of Compatible Origins of Replication 
The pBR322, RSF1030 and p15a origins of replication are often used in cloning vectors. Though 
these plasmids all use the same unidirectional mechanism of replication dependent on an RNAII 
primer, they fall in different incompatibility groups and can hence be mainatained in the same cell. 
These origins have an additional benefit of having copy numbers ranging from 10 for p15a, 15-20 
for pBR322 to 100 for RSF1030. Variants of pBR322 (namely pUC) or RSF1030 (namely 
RSF1031) can have very high copy numbers of 500-700 copies/cell.  An alignment of the RNA 
pBR322, p15a and RSF1030 origins of replication allows us to map the RNAII priming region 
(Fig. 4.1). ColE1 is included in the alignment for comparison. The RNAI sequence, including its 
-10 and -35 promoter regions, are identical in all four replication origins. The RNAII sequences, 
differ between pBR322, p15a and RSF1030 which places them place them in different plasmid 
incompatibility groups. Note that ColE1 and pBR322 fall within the same group. The native -10 
and -35 regions of the RNAII promoter were replaced with a Lac promoter under LacIQ control. 
Thus, RNAII production, and hence DNA replication, becomes dependent on induction by IPTG. 
  
4.3.2 Relative Copy Numbers of Different Origins  
pAM34 has a pBR322 origin of replication and is a 6 kb plasmid. Cronan73 has shown that pAM34 
has a slightly higher copy number (1.5 times) than a standard cloning vector with a pBR322 origin 
which has a literature value of 20. Plasmid pI1030 is observed to have a very similar copy number 
to pAM34 (Fig. 4.3) whereas the p15a origin of plasmid pI15 is only 60% of pAM34 giving it a 
copy number closer to that of a classical pBR322 plasmid like pBAD322S 73. RSF1030 is a 
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medium copy origin (100 copies/cell). However, under lacZp control, significantly lower copies 
are seen.  Moreover, the lacZ promoter has been previously shown to be fully induced at 1mM 
IPTG. Plasmid pI1031 has a single base change from pI1030 that is shown to increase copy 
numbers to pUC-like numbers (400-500). Though the copy number of pI1031 is roughly twice 
than pI1030 and pAM34, its copy number of 60 is lower than that of a classical RSF1030 origin. 
 
Omitting ampicillin selection pressure, albeit during the first 6-7 generations, had very little 
influence on the copy number with a 5-10% depression in copy number observed. However, 
without IPTG, the copy numbers fall precipitously with pAM34 being the only plasmid still 
maintaining about 30% of its original copy number.     
 
4.3.3 Dynamics of Curing of the pI series of Plasmids 
pAM34 was shown to require IPTG concentrations of >500 nM for effective maintenance. By 
measuring plasmid yields from cultures grown in differing IPTG concentrations, all plasmids 
tested showed a 15-20% decrease in plasmid concentration when grown with only 0.1 mM IPTG 
(Fig 4.4). Since E. coli has an active lactose transporter, lacY, it is possible that higher intracellular 
concentrations are maintained. However, unlike plasmids pI15 and pI1030 which are efficiently 
lost when IPTG is withdrawn, pAM34 cultures retain 35-40% of their plasmid content.   
 
When colonies grown with ampicillin and IPTG are streaked on an LB plate, almost all colonies 
were observed to have lost the plasmid. This was verified by screening for loss of ampicillin 
resistance and by attempting to purify plasmids from a small subset of colonies. Cultures carrying 
pI15, pI1030 and pI1031 completely lost their plasmids within 15 doublings, with pI15 and pI1031 
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losing more than 50% in less than 5 generations. pI1030, however, experiences complete plasmid 
loss in a similar time frame as the other two. Meanwhile, pAM34 requires more than 25 generations 
to get fully cured. The pAM34 curing rate agrees with similar observations made by Gill and 
Bouche 74, in the original report of pAM34. 
 
4.3.4 Description and Validation of the Two-plasmid System in E. coli 
To establish and improve the speed and utility of CRISPR/Cas based genome editing in E. coli, a 
two-plasmid system was constructed consisting of pITRCas9 and pSgRNA plasmids (Fig. 4.6). 
pITRCas9 encodes the S. pyogenes Cas9 endonuclease with an ssrA degradation under a 
tetracycline-inducible promoter, has the λ beta, gamma and exo genes under pBAD control and a 
p15a origin whose replication requires the presence of IPTG. The guide RNA plasmids encode a 
single guide RNA (pSgRNA) under a tetracycline promoter and contain an orthologous rpsL 
counterselection marker to allow for rapid curing of the plasmid in a streptomycin resistant strain. 
New spacers were introduced in pSgRNA using a PCR based cloning strategy.  Alternatively, two 
Bbs1 sites were also used to introduce spacers using a golden gate approach (Fig. 4.6) 
 
The effectiveness of the plasmids was tested by using guide RNA targeting the essential gene dnaG 
in E. coli BW25113 (Fig. 4.8). In the presence of anhydrotetracycline, a 104-fold reduction in 







4.3.5 Oligonucleotide-mediated Ts Mutations 
CRISPR/Cas has been shown to be an effective scarless counterselection for generating point 
mutations using single stranded donor DNA. We demonstrate the particular utility of this tool in 
generating a point mutation in an essential gene cluster that results in a temperature sensitive yet 
plasmid free strain. Most genes in the fatty acid biosynthetic operon are essential and the most 
convenient way to study them has been using temperature sensitive variants that grow at lower 
temperatures but lose function at higher temperatures. Using pSgRNA-fabG, a single guide RNA 
that targets the 714th base of fabG (Table 4.3), and an oligonucleotide resembling the lagging 
strand, we successfully introduced a E233K mutation in fabG with an efficiency of 99% (Table 
4.4). 
 
4.3.6 Short Deletions 
Expression of the λred genes has been successfully used in the past for ssDNA mediated deletion 
up to 45 kb of the genome. We used a sgRNA and an oligonucleotide to target and delete a short 
32 bp sequence from the fabG gene that corresponds to an 8 residue in-frame deletion in the gene. 
Of the 72 colonies tested, 94% had the deletion (Table 4.4). This was first tested by temperature 
sensitive growth and then by sequencing. 
 
4.3.7 Short Sequence Insertions  
We tested the ability of this system to insert short sequences into the E. coli genome. λRed- 
mediated recombination has been used to make both large and small insertions using just 50 bp 
regions of homology using donor dsDNA. However, to introduce short tags like the hexahistadine 
tag (6X-His), ssDNA has been used to insert up to 30 bp. We use a 95 bp ssDNA to insert a 24 bp 
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hexahistidine tag with a Gly-Gly linker at the C-terminus of fabG. We obtained mutants at an 
efficiency of 90% (Table 4.4). Colonies were first tested for the insertion via PCR and 
subsequently confirmed by sequencing. Nine colonies were tested.     
 
4.3.8 Speed and Efficiency of Plasmid Curing  
Due to the limited availability of compatible origins of replication and commonly used genetic 
markers for strain manipulations, recombineering methods resulting in strains free of plasmids are 
generally preferred. The pITRCas9 construct is based on the pI15 vector backbone. Vector pI15 
was shown to be cured within 12-15 generations. Given the large payload and hence the size of 
pITRCas9, the copy number is expected to be much lower. pITRCas9 can hence be completely 
cured in less than 6-7 generations which is easily achievable in a single culture grown to saturation. 
Meanwhile, pSgRNA can be cured by growing the strain in liquid culture in the presence of 
streptomycin (300 μg/ml) and then plated on LB agar plates with the same streptomycin 
concentration. The two independent curing mechanisms can be utilized to facilitate either 




CRISPR/Cas systems were originally identified for their role in bacterial adaptive immunity but 
have recently taken the scientific world by storm due to their remarkable ability to target complex 
genomes with just a small guide RNA. In prokaryotes, recombineering using phage derived 
recombination machinery remains one of the most effective methods of genetic engineering. 
However, the major limiting aspect of this remains the process of selecting mutants over wild-type 
95 
 
cells. The combination of recombineering with CRISPR/Cas9 based counter-selection systems has 
greatly enhanced the effectiveness of this selection process and have since been incorporated into 
a number of tools for microorganisms into which plasmids can be introduced like E. coli, S. 
pneumoniae, L. reuteri and T. citrea amongst others. Though single-plasmid systems containing 
the guide RNA, the endonuclease and/or the donor DNA have been devised for other bacteria and 
eukaryotes, this is not possible in the specific case of E. coli if it also has to be used as a cloning 
host. Jiang et al first demonstrate its utility in E. coli with two plasmids, one encoding the spCas9 
and the other with a CRISPR array targeting a gene of interest. This arrangement requires 
expression of the λred genes, either from the genome or on a third helper plasmid in order to use 
ssDNA or short dsDNA as recombination templates. Further iterations have combined different 
combinations of Cas9, λred and guide RNA (sgRNA or crRNA) in a two-plasmid format under 
either constitutive or inducible promoters. Recently reported tools also utilize temperature 
sensitive origins of replication to facilitate guide RNA plasmid curing at higher temperatures but 
still require specific efforts to cure the Cas9 encoding plasmid, costing time in iterative editing 
efforts.  
 
In this Chapter, I present a convenient and facile two-plasmid system. The first plasmid 
(pITRCas9) encodes Sp. Cas9 under a tetracycline inducible promoter, the λred genes under an 
arabinose inducible expression and an IPTG-dependent origin of replication. The second plasmid 
contains a single guide RNA (pSgRNA) also under tetracycline control with an rpsL 
counterselection system. This combination provides some unique advantages and facilitates ease 
of use. The pSgRNA plasmid is small (~4 kb) and new protospacers can be introduced via a single 
PCR reaction followed by circularization and transformation into a cloning host like DH5α. The 
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empty vector also has BbsI sites that maybe used with short annealed oligos for Golden Gate 
cloning. Multiple spacers may also be cloned into either vector using synthesized DNA blocks 
and/or Gibson assembly to simultaneously target multiple genes. Since the plasmids can be 
independently cured, loss of either one or both plasmids can be achieved in a single step depending 
on whether pITRCas9 is required for subsequent edits or not. Also, since this may be performed 
independent of any strain specific temperature requirement, cloning, growth, recombination and 
curing may be performed at the any temperature optimal for the experimental design.  
 
A typical workflow for introducing a single change takes about 4 days from start to finish which 
is almost twice as fast than any currently available system to obtain plasmid free strains. Further, 
changes may be achieved in half the time. The rpsL counterselection system uses a wild-type rpsL 
gene from Photorhabdus luminescens that confers a dominant sensitivity to streptomycin in a 
streptomycin resistant background. The sequence of the P. luminescens rpsL gene has been 
optimized for use in E. coli and has been verified to have no significant stretch of homology to the 
endogenous rpsL gene. The only requirement for rpsL based counterselection is a streptomycin 
resistant background that is easily achieved by either using some popular strains such as Top10, 
MC4100, MC1061, JM103, JM105, JM83, EPI300, DH10B, AB1157 and their derivatives or by 
simply transforming a short oligo to introduce a point mutation in the wild type rpsL gene and 
selecting for streptomycin resistance, as shown in BW25113 to generate SW02.  
 
Most escapers observed in E. coli maybe attributed to a mutation in either the Cas9 nuclease or the 
spacer sequence. This is an exploding field of study and more efficient Cas9 nucleases are being 
discovered/developed. Given its size, the cas9 gene is a large target for mutations. In a scenario 
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where iterative changes are required, this can prove to be cumbersome since curing the Cas9 
encoding plasmid and swapping it out for a new one might be rate-limiting. This plasmid can be 
potentially shortened by including the repressive elements such as LacIQ, TetR and AraC on the 
host genome. However, the biggest improvement might come from discovery of minimal or 
smaller Cas9 nucleases.  
 
Plasmid pITRCas9 is itself based on pI15 which has a IPTG-dependent p15a origin of replication. 
p15a has a low copy number of 10-15 and thus might be useful to reduce any potential toxicity 
that Cas9 might have prior to induction. The differing copy numbers provided by pI1030, pI1031 




4.5 TABLES AND FIGURES 
 
Strains Relevant Genotype Source 
MC1061 Wild type strain Casadaban, et 
al., 1980 




BW25113 lacI+rrnBT14 ΔlacZWJ16 hsdR514 ΔaraBADAH33 
ΔrhaBADLD78 rph-1 
CGSC #7636 
SW02 BW25113 rpsL135 (strR) This work 
 




Plasmids Relevant Characteristics Source 
pAM34 IPTG-dependent plasmid with pBR322 ori  Gill et. al, 
1991 
pACYC184 Cloning vector with p15a ori Chang et. al, 
1978 
pCY2016 pBAD plasmid with RSF1030 ori; medium copy no Chakravartty 
et al, 2015 
pCY2017 pBAD plasmid with RSF1031 ori i; high copy no Chakravartty 
et al, 2015 
pI15 IPTG-dependent plasmid with p15a ori  This work 
pI1030 IPTG-dependent plasmid with RSF1030 ori  This work 
pI1031 IPTG-dependent plasmid with RSF1031 ori  This work 




pCas9CR4 Cas9 nuclease under pTet promoter and constitutive TetR Reisch et al, 
2015 
pKDsgRNA-p15 pSC101 (Ts) origin; Tet-inducible protospacer targeting 
the p15a ori, Ara-inducible λred, SpecR 
Reisch et. al, 
2015 
pSW09 pCas9CR4 with IPTG-dependent replication This work 
pSW10 pKDsgRNA-p15a w/o λred, pSC101 Ts, AmpR This work 
pSW11 pSW10 non-Ts, AmpR This work 
pITRCas9 IPTG-dependent replication, Ara-inducible λred, Cas9 
under pTet promoter; CmR  
This work 
pSgRNA pSC101 (non-Ts); AmpR; protospacer sequence with Bbs1 
sites, Tet-inducible guide RNA production 
This work 
pSgRNA-p15a Protospacer targeting p15a origin; ctatcgtcttgagtccaacc This work 
pSgRNA-dnaG Protospacer targeting dnaG; ggagctctggacattaaacc This work 
pSgRNA-fabG Protospacer targeting fabG; ggtgaaactttgcatgtgaa This work 
pSgRNA-fabG2 Protospacer targeting fabG; tgtgaacggcgggatgtaca This work 
 





p15a Kpn1 ATGCCAGGTACCTTGCTCTGAAAACGAAAAAACCGC 
p15a Xba1 GATCCATCTAGAACTAGAGTCACACTGGCTCAC 
RSF Kpn1 ATGCCAGGTACCTCATAAATAAAGAAAAACCACCGC 
RSF Xba1 GATCCATCTAGACTCTTTTGTTTATTTTTCTAAATACATTC 
p34C AatII F  ATCGAGACGTCTTGAAATAAGATCACTACCGGG 
p34C Xba1 R 
ATGCCATCTAGAGGATCCGCATGCCTGCAGGTCGACAAGCTTC
CCGGGTACCGAGCTCGCGAATTTCTGCCATTCATC 
p34K AatII F ATCGAGACGTCCCACGTTGTGTCTCAAAATCTCTG 
p34K Xba1 R ATGCCATCTAGAGGATCCGCATGCCTGCAGGTCGACAAGCTTC
CCGGGTACCGAGCTCCGCTGAGGTCTGCCTCG 
p34G AatII F ATCGAGACGTCGAATTGACATAAGCCTGTTCGGTTCG 
 p34G Xba1 R ATGCCATCTAGAGGATCCGCATGCCTGCAGGTCGACAAGCTTC
CCGGGTACCGAGCTCGAATTGGCCGCGGCGT 
p15a-lacI Spe1 F  TCTAGAACTAGTGAAACCATTATTATCATGACATTAACC 
p15a-lacI Age1 R CGGTTTACCGGTGTCATTC 
LRed AatII F  ATGCCAGACGTCCATCGATTTATTATGACAACTTGACGG 




Amp Nco1 F  ATGACACCATGGTAAATACATTCAAATATGTATCCGCTC 
Amp Xho1 R GCATGACTCGAGGTAAACTTGGTCTGACAGTTAC 
Non Ts F GCTTACTTTGCATGTCACTC 
Non Ts R ATGATCTCAATGGTTCGTTC 
pSgRNA-dnaG F GGAGCTCTGGACATTAAACCGTTTTAGAGCTAGAAATAGCAAG 
pSgRNA-fabG F GGTGAAACTTTGCATGTGAAGTTTTAGAGCTAGAAATAGCAAG 
pSgRNA-fabG2 F TGTGAACGGCGGGATGTACAGTTTTAGAGCTAGAAATAGCAAG 
pSgRNA R GTGCTCAGTATCTCTATCACTGA 
pSgRNA check GCTACGCCTGAATAAGTG 
 




Target Mutation CFU Positives  
Control None 5.2 x 107 N.a.  
dnaG None 2.7 x 103 N.a.  
fabG Ts (point) 4.5 x 105 99 ± 1%  
fabG 24bp deletion 1.7 x 104 94 ± 3%  
 





Figure 4.1 Comparison of RNA I and RNA II binding sequences of different replication 
origins. Alignment was performed with ClustalW. Conserved sequences are highlighted in black. 
The -10 and -35 boxes of the RNA II and RNA I are indicated in red. Known RNA II primer 
sequence of pBR322 is indicated in green while the RNA I sequence is in blue.  Strong conservancy 
is observed between the -10 and -35 boxes of p15a, pBR322 and ColE1. However, the RNA II 





Figure 4.2A Plasmid maps of pI15 and pI1030. pI15 and pI1030 are smaller than pAm34 due to 
deletion of rop along with the pBR322 origin. rop is shown to not function with the p15a origin of 
replication. Other elements including the multiple cloning site (MCS), aadA gene and the direct 
repeat regions found in pAM34 are intact. Antibiotic resistance markers are in green and 





Figure 4.2B Plasmid maps of pIBRC, pIBRK and pIBRG are shown. These plasmids are much 
smaller than pAM34 and are resistant to chloramphenicol, kanamycin and gentamycin 
respectively. They are missing the aadA gene and the old MCS. The restriction sites present in the 







Figure 4.3 IPTG-dependent replication of pAM34, pI15, pI1030 and pI1031. Plasmids were 
extracted from 1ml of an LB culture grown to OD 1.0 from OD 0.01 with the following 
supplements. AI represents addition of ampicillin (100ug/ml) and IPTG (1mM), I represents 
addition of IPTG (1 mM) only while – represents no supplementation. Relative plasmid amounts 
are indicated in the bar graph below with pAM34 set as 100.  All four strains show plasmid loss 
in the absence of IPTG while the lack of ampicillin selection has minimal to no effect in 6-7 






Figure 4.4 Changes in plasmid levels with varying IPTG concentrations. Plasmids were 
extracted from 1 ml of an LB culture grown to OD 1.0 from OD 0.01. Cultures were supplemented 
with varying IPTG amounts as indicated above each lane. Relative plasmid amounts are indicated 
in the bar graph below with pAM34 set as 100.  All four strains show plasmid loss in the absence 
of IPTG while the lack of ampicillin selection has minimal to no effect in 6-7 generations. Marker: 






Figure 4.5 Rate of curing of pAM34, pI15, pI1030 and pI1031. Plasmid curing was measured 
over 25 generations in LB with no IPTG supplementation. Cultures were started at OD 0.01 and 
samples were withdrawn periodically and plated on LB agar with 1 mM IPTG. OD measurements 
were used to calculate number of generations grown. Samples were re-diluted to OD 0.01 when 
an OD of 1.0 was achieved. Ratio of ampicillin resistant colonies to total number of colonies is 
represented against number of generation. Thirty six colonies were analyzed for each time-point.  
Strains are cured of pI15, pI1030 and pI1031 within 15 generations and at a significantly faster 
rate than pAM34 which was not completely cured even after 25 generations. Hence, pI1030 and 





Figure 4.6 Plasmid maps of the CRISPR/Cas9 vectors. Plasmid maps show key features of both 
plasmids. pITRCas9 contains cas9 under a tetracycline-inducible promoter. The tetracycline 
repressor is expressed from its own promoter. The lambda RED genes are under arabinose control 
with constitutive expression of AraC from its own promoter. Replication is from a p15a origin. 
The RNA II primer is under a lacZ promoter and hence replication is IPTG-dependent. pITRCas9 
confers resistance to chloramphenicol.  pSgRNA as a non-temperature sensitive pSC101 origin 
and is confers ampicillin resistance. It contains a tetracycline inducible single-guide RNA. The 
empty vector has a protospacer (depicted below the map) that has Bbs1 sites for golden gate 
cloning and a Nco1 site (1 of 3) for quickly verifying protospacer insertion. Two strategies for 
cloning are depicted below: a PCR based approach that includes the protospacer sequence on one 
primer and a golden gate approach that requires specific overhangs included with the protospacer 





Figure 4.7 Schematic for single/iterative knockouts. pITRCas9 and pSgRNA are sequentially 
transformed into the host strain. Lambda red is induced during competent cell preparation and 10 
mM of donor DNA is transformed. IPTG is added during recovery but can be omitted while plating 
to induce curing of pITRCas9. For iterative changes, pSgRNA can be selectively cured by growing 
on streptomycin containing media (provided the host is streptomycin resistant) and transforming 





Figure 4.8 Efficiency of killing.  Ten ul of a ten-fold serial dilution of strain BW25113 containing 
pITRCas9 and pSgRNA-dnaG was plated on LB agar plates with or without 100 ug/ml 








Fatty acids are an essential component of living organisms. Though they serve multiple roles both 
inside and outside the cell, in bacteria their primary purpose is to build the cellular membranes.  
The composition of these membranes is carefully regulated to maintain its functionality under 
various physiological and stress conditions. Since fatty acid synthesis is energetically expensive, 
these processes are regulated at multiple levels. Individual examples of this in E. coli include the 
regulation of acetyl-CoA carboxylase by phosphorylation and allostery and transcriptional 
regulation of unsaturated fatty acid synthesis by the repressor FabR.  Other organisms which can 
shuttle intermediates between their fatty acid biosynthetic and degradation pathways show even 
more complex regulation. A holistic picture of this regulation is unavailable because of a lack of 
clarity regarding the composition of intermediates at any given condition.  
 
In Chapter 1, I present a rapid and facile method to isolate and characterize the ACP bound 
intermediates from E. coli and B. subtilis. This method requires a single genetic change to insert 
an inert Strep-tag at the carboxy-terminus of ACP on the chromosome. In E. coli and B. subtilis, 
this change has no effect on the growth of the organism or the functionality of the ACP protein. 
The ACP isolation steps are otherwise unaffected by any other genetic change or treatment being 
tested. A significant amount of acetyl-ACP was discovered in both E. coli and B. subtilis. This 
raises certain pressing questions such as whether acetyl-ACP is metabolically active and, if so, 
why such a significant amount of carbon is dedicated to this intermediate. Given the non-
essentiality of fabH and the detection of acetyl-ACP, a robust bypass pathway probably exists in 
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E. coli that can condense acetyl-ACP with malonyl-ACP. Discovering this enzyme might not be 
trivial because no other gene is found to be overexpressed in fabH mutants in comparison to the 
wildtype. Observing changes in the acetyl-ACP pool in fabH, fabD, fabB and fabF mutants might 
provide a clue. Further, the use of fatty acid initiation inhibitors like cerulenin and thiolactomycin 
might also demonstrate how this metabolic pool varies.  
 
We observe no other dicarboxylic acyl-ACPs other than malonyl-ACP in both E. coli and B. 
subtilis. The biotin biosynthetic pathway in B. subtilis is complicated and not completely 
elucidated. Though we know that B. subtilis uses a free pimelic acid precursor that is directly or 
indirectly synthesized through the fatty acid pathway, the source of this remains a mystery. Biotin 
auxotrophic mutants in B. subtilis might accumulate certain early precursors providing a clue to 
drive further research in this area.  
 
The current view of bacterial fatty acid synthesis is still quite E. coli centric, and numerous 
examples exist of other bacteria following ‘new rules’. The abundance of ACP in E. coli has given 
us the false perception that ACP itself cannot be a limiting factor in fatty acid related processes. I 
show through multiple independent approaches that B. subtilis also has only a tenth of the ACP 
present in E. coli. Preliminary evidence from other Gram-positive and Gram-negative bacteria 
indicates that this paucity might be more prevalent. In B. subtilis, ACP associates very tightly with 
FabF, with this interaction persisting through multiple purification columns. Perhaps this tight 
interaction is part of a larger loose complex of fatty acid enzymes that effectively increases the 
local availability of ACP to its cognate enzymes. Current efforts are focusing on seeing if the 
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reciprocal interaction can be observed wherein ACP (and perhaps the other fatty acid synthesis 
enzymes) co-elute(s) during FabF purification. 
 
Meanwhile, one of the most direct utilities for the method remains for system biologists and 
synthetic biologists. An acyl-ACP snapshot would allow us to trace metabolic fluxes through the 
fatty acid pathway in an unprecedented manner. This would allow them to fine tune metabolic 
models to accommodate their observations. This is especially useful when used in an industrial 
organism wherein productivity can be rationally improved.  
 
In Chapter 3, I characterized a novel temperature-sensitive mutant of E. coli FabG and 
demonstrated this temperature-sensitivity to be due to the loss of an eight-amino acid section that 
consequently reduced dimerization. By mutating the wildtype copy of this gene on the E. coli 
genome, its effects on phospholipid synthesis and lipid A synthesis could be investigated. 
Interestingly, the defects in this mutant could be compensated by simultaneously mutating a gene 
in lipid A synthesis, lpxC, suggesting that this is a point of regulation between these two pathways 
towards balanced growth. The mutant also, surprisingly, reverted to temperature-resistance with 
the frequency of a point mutant. Sequencing these revertants showed that this was caused by other 
compensatory mutations in the dimer interface. An exhaustive search for all compensating 
mutations was not performed. Almost no drugs that target FabG exist, even though FabG homologs 
are found in almost all bacteria and they all function as multimers. Identifying and characterizing 
the suppressive mutants might contribute to a better understanding of the specific interactions 




In Chapter 4, I describe the development of a CRISPR/Cas9 toolkit along with a new set of vectors 
that have facilitated studies in the previous chapters. These are conditional vectors that can 
replicate only in the presence of IPTG. These plasmids utilize origins of replication that all require 
the production of a RNA II primer that binds to the origin and initiates DNA replication. 
Transcription of this RNA primer has been placed under a lacZ promoter which is repressed by 
LacIQ in the absence of IPTG. This has been extended to other compatible plasmids that have a 
RNA II-based mechanism of initiation but with different primer sequences. These plasmids can be 
reliably cured within 15 generations with more than 50% of plasmid loss occurring within the first 
five generations. 
 
A CRISPR/Cas9 vector toolkit has also been developed wherein the expression of the Cas9 
nuclease is under a tightly regulated tetracycline promoter while the replication of the plasmid 
itself is IPTG-dependent and is built off the previously described plasmids. This allows this 
plasmid to be rapidly cured from strains where the genetic manipulations are complete. The system 
is effective and can provide a 104-fold selection for recombination. This is comparable with other 
CRISPR/Cas9 systems. The second plasmid contains a single guide RNA also under tetracycline 
control and a rpsL counter-selectable marker. Wildtype rpsL confers dominant streptomycin 
sensitivity. In a streptomycin resistant background strain, plasmid loss can be selected for by 
growing the plasmid carrying strain in the presence of streptomycin. Another approach being 
explored is expressing a chromophore, wherein strains which have lost a plasmid can be 
immediately identified by loss of color. Interestingly, both plasmids can co-exist in the cell without 
inducing a double strand break if they are transformed sequentially and in the absence of inducer. 
This suggests that it might be theoretically possible to incorporate both the guide RNA and Cas9 
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on the same plasmid under the same tetracycline promoter, provided the tetracycline repressor is 
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COPING WITH INADVERTENT LYSIS OF ESCHERICHIA COLI CULTURES: 
GENERATION OF STRAINS RESISTANT TO LYSOGENIZATION AND INFECTION 
BY THE STEALTHY LYSOGENIC BACTERIOPHAGE Φ80 
 
Phages are the most abundant biological entities on Earth and understanding their pivotal role in a 
variety of biological and environmental processes has led to some of our most meaningful 
advances in molecular biology. Most of the known phages are virulent and invariably lyse their 
hosts in their normal life cycle. However, some phages, called lysogenic (temperate) phages, can 
remain as quiescent integrants (prophage) of the host replicon that are passively replicated by the 
host until conditions become favorable for lytic growth. These prophages are surprisingly 
common, with one study finding 51 different functional phages released from 27 different 
Escherichia coli strains 75 and another showing that 83 of 107 E. coli strains released at least one 
functional phage type 76.  Ultimately, these phage elements can account for up to 20% of the 
genomic DNA of their hosts 77. 
 
Recent reports have described a lysogenic bacteriophage (Lula, later shown to be Φ80) that resides 
in many laboratory Escherichia coli strains 78,79.   Phage Φ80 infects other E. coli strains and 
spreads quickly and is generally not detected in aseptic laboratory conditions due to its strong 
propensity to lysogenize 78.  However, Φ80 lysogens are much less stable than those of phage λ, 
the paradigm lysogenic phage, 79-81and spontaneously release large numbers of infectious phage 
particles. The presence of Φ80 phage particles in the medium of growing cultures is due to 
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induction by spontaneous DNA damage 78,79 whereas induction of phage λ lysogens requires much 
higher levels of DNA damage. The high titers of infectious Φ80 phage in the growth medium often 
accumulate without apparent lysis since most of the cells remain lysogens. The infectious virions 
are readily spread because they are stable in aerosols and to desiccation. Regardless, Φ80 lysogens 
have avoided detection, persisted for decades and are more prevalent than one might suspect. One 
reason, noted above, is the Φ80 preference for lysogeny upon initial infection. The second 
important factor is that Φ80 lytic development is very temperature dependent. Phage production 
is rapid at <30C, slow at 37C (the temperature at which E. coli strains are commonly grown), 
and is essentially blocked at 42C. Indeed, lysis due to Φ80 is most commonly seen in cultures 
grown at 28-30C, the permissive temperature of the temperature sensitive (Ts) strains used to 
study function of genes essential for growth such as those of DNA replication and membrane lipid 
synthesis. Moreover, growth of E. coli strains at temperatures <30C is often used in high-level 
protein production.  Indeed, the ability of Φ80 to flourish at low growth temperatures was key to 
its detection. We have observed Φ80 phage lysis of E. coli cultures in our laboratory and other 
laboratories report this extends to some strains from the E. coli Genetic Stock Center. We have 
sought to alleviate this problem by generating and characterizing a set of commonly used E. coli 
strains that cannot be infected. These, otherwise ‘wild type’, E. coli strains should allow effective 
control of the spread of Φ80.    
  
We first considered adsorption of Φ80 to its E. coli host. Phage Φ80 has been shown to require the 
outer-membrane receptor FhuA, also known as TonA, for adsorption to the host.  FhuA is coupled 
to the energized cytoplasmic membrane through TonB and both are required for Φ80 adsorption 
to be irreversible 82-84. We constructed tonA and tonB strains in E. coli strain BW25113 by 
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replacing the genes with a kanamycin resistance cassette using the method of Datsenko and 
Wanner 33,85 and primer sets del tonA UP/del tonA DN  and del tonB UP/del tonB DN, respectively. 
A Φ80 stock was prepared by growing a Φ80 lysogen (BW25113::Φ80) at 37C overnight and 
then lysing the culture by adding a few drops of chloroform and removal of the cell debris by 
centrifugation.. The supernatant was titered by plating serial dilutions on wild type BW25113 and 
assay of plaque forming units. To test susceptibility to Φ80 infection, exponentially growing 
cultures were incubated with a Φ80 phage stock (titer 109 pfu/ml) and plated on LB agar plates 
and incubated at 30C overnight. Both fhuA (tonA) and tonB strains were resistant to Φ80 infection 
while a control non-lysogenic BW25113 strain showed complete lysis (Fig. A.1).  However, it 
should be noted that fhuA (tonA) and tonB mutant strains are deficient in the uptake of ferric 
enterochelin, ferric citrate and vitamin B-1282,83  and thus cannot be used to study iron metabolism 
and related processes such as oxidative stress mediated by the Fenton reaction. In early work tonB 
mutations were used to make strains resistant to phage T1 (hence the ton designation) which uses 
the same receptor as Φ80  (many of the reported infections by phage T1 may well have been Φ80 
infections given that Φ80 was a more mainstream phage 86. However, a disadvantage (now passé) 
of tonB strains was sensitivity to the chromic acid then used to clean glassware 87. For this reason, 
tonB mutations were replaced by the fhuA (tonA) mutations which are present in several 
commercially available cloning and expression strains.  
 
The primary bacterial attachment site (attB80) of Φ80 was mapped 88 to be near the trp locus. 
Comparison of the core sequence of attB80 to the published sequence of the E. coli K-12 strain 
MG1655, located it to the last 19 nucleotides of the gene yciI (Fig. A.2B), which is directly 
adjacent to tonB (albeit divergently transcribed). The yciI gene encodes a non-essential protein of 
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unknown function and seems independently transcribed. Considering the genomic context of the 
integration site within yciI and its immediate neighbor tonB, the yciI759::Kan  mutant 
(henceforth referred to as yciI Kc) available from the Keio collection was tested for its ability to 
be lysogenized by Φ80. The lysogeny test is based on the fact that Φ80 lysogens are immune to 
superinfection by the same phage. An exponentially growing culture of BW25113 was inoculated 
with a Φ80 phage stock (multiplicity of infection <1) and allowed to grow for 15 min at 37C 
before being plated on LB-agar plates incubated at the same temperature overnight. Surviving 
colonies were grown to OD600 of 0.2 at 37C and cross-streaked against a high-titer Φ80 phage 
stock. The growth of yciI Kc beyond the cross-streak indicated that the strain was a Φ80 lysogen 
which blocked infection (Fig. A.3B). The medium of the yciI Kc was also found to contain very 
high phage titers (>107), comparable to a wild type lysogen (Fig. A.3A).  
 
These results motivated us to construct wild type laboratory strain(s) that could not be efficiently 
lysogenized. Two different strains were constructed (Fig. A.2A). In one (called BW25113 
∆attΦ80) the chromosomal attachment site was deleted. The other strain (attΦ8*) had a mutated 
attachment site core region sequence that was altered without changing the amino acids encoded 
in the carboxy terminus of the YciI protein (Fig. A.2C). Both mutant strains were constructed as 
described above using primer sets del att UP/del yciI DN and mut att UP/del yciI DN (Fig. A.2A). 
When tested for lytic infectivity, both strains showed remarkably lower phage production (at least 
1000-fold lower). Also, when tested for lysogeny, neither strain could grow beyond the cross-
streak, implying that they could not form Φ80 lysogens.  This was verified by PCR amplification 
across the attB site using primers Lys check F/Lys check R. The presence of an amplified band 
indicated that the site was intact (Fig. A.3C) whereas integration of the large phage genome 
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(46,150 bp) would result in the lack of a band due to the inability of PCR to pr4ogress across the 
phage genome. We also constructed a complete deletion of yciI leaving only its stop codon 
(∆yciI::Kan) and a deletion of the entire genomic region from the end of yciI to the end of tonB 
(∆yciI-tonB::Kan ; Fig. A.2A). The kanamycin resistance cassette is flanked by a pair of FRT sites 
and can be easily removed by expressing the FLP recombinase encoded on plasmid pCP20 33 but 
the cassette was left intact to facilitate movement into other strains by P1 transduction. 
 
Note that the yciI-tonB deletion in the chromosome of strain SW07 and thus this strain lacks both 
the chromosomal attachment site (attB80) and the TonB Φ80 outer membrane receptor. Hence, 
this strain can neither be infected by Φ80 nor efficiently form Φ80 lysogens.  The presence of both 
mutations may seem redundant. However, note that Φ80 genomes can enter strain SW07 by means 
that do not require the TonB receptor, such as by phage P1 transduction using a phage stock grown 
on a Φ80 lysogen. Phage P1 readily packages prophages λ and Φ80 together with the flanking 
bacterial chromosomal segments 38,89,90.  Upon introduction of the Φ80 genome by P1 transduction 
the phage can be inserted into the E. coli chromosome either by the standard lysogenic pathway or 
by homologous recombination using the flanking host sequences. It should be noted that like phage 
λ, Φ80 can insert into secondary attachment sites 91. However, integration into secondary 
attachment sites occurs at a very low frequency (~10-6 of the normal frequency of lysogeny). 
Moreover, excision of Φ80 from the secondary sites is very inefficient (10-4 -10-5) relative to 
excision from attB80 91. The combined low frequencies of these events argue that the secondary 




In conclusion, the yciI-tonB::kan deletion can be readily moved to other E. coli strains to avoid 
lysis by phage Φ80 and prevent propagation and spreading of this robust phage to the environment.  
A.1 TABLE AND FIGURES 
 
Bacterial Strains 
Strains Relevant Genotype Source 
BW25113 lacI rrnBT14 ΔlacZWJ16 hsdR514 ΔaraBADAH33 
ΔrhaBADLD78 rph-1 
CGSC #7636 
BW25113::Φ80 Φ80 lysogen Personal gift 
of A. 
Kuzminov  
JW1243 BW25113 ∆yciI759::Kan ; Also called ∆yciI Kc Keio 
collection 
SW03 BW25113 ΔtonA::Kan This work 
SW04 BW25113 ΔtonB::Kan This work 
SW05 BW25113 ∆attB80::Kan This work 
SW05  BW25113 mut attB80::Kan This work 
SW06 BW25113 ∆yciI::Kan This work 
SW07 BW25113 ∆yciI-tonB::Kan  This work 
   
Plasmids 
Plasmids Relevant Characteristics Source 




pKD4 AmpR  pir dependent  provides FRT-KanR-FRT Datsenko and 
Wanner, 2000 
   
Oligonucleotides 
Oligonucleotides Sequence 
del tonA UP ATCATTCTCGTTTACGTTATCATTCACTTTACATCAGAGATATA
CCAATGGTGTAGGCTGGAGCTGCTTCG 
del tonA DN GCACGGAAATCCGTGCCCCAAAAGAGAAATTAGAAACGGAAG
GTTGCGGTCATATGAATATCCTCCTTAGT 
del tonB UP ATTTAAAATCGAGACCTGGTTTTTCTACTGAAATGATTATGACT
TCAATG CATATGAATATCCTCCTTAGT 
del tonB DN CTGTTGAGTAATAGTCAAAAGCCTCCGGTCGGAGGCTTTTGAC
TTTCTGCGTGTAGGCTGGAGCTGCTTCG 
del yciI UP CCCTTTCAAATAACGTACTTTACAACTTTCCCGAACAAGGAGTT
GTGCCCGTGTAGGCTGGAGCTGCTTCG 
 





Table A.1 (cont.) 
mut att UP ATGCTGACCCGTACGTAGCGGCAGGAGTCTATGAACACGTTTC
AGTGAAGCCTTTCAAAAAGGTCTTTTGAGTGTAGGCTGGAGCT
GCTTCG 
del yciI DN AAACAAGAACACGGTTGCAAAAACCGTGCCCTTAAATATTGAA
TCTCTATCATATGAATATCCTCCTTAGT 
del att UP ATGC TGACCCGTAC GTAGCGGCAG GAGTCTATGA 
ACACGTTTCAGTGTGAGTGTAGGCTGGAGCTGCTTCG 
Lys check F CTTTATGCATGGCCTTAACAAAGAC 






Figure A.1 Lysis by phage Φ80. Exponentially growing cultures of E. coli strains BW25113, 
BW25113 ∆tonA and BW25113 ∆tonB strains were infected with 10 µl of a phage Φ80 stock and 
plated on LB agar. BW25113 ∆tonA and BW25113 ∆tonB could not be infected by Φ80 as inferred 
from the lack of clearing. In contrast strain BW25113 plate showed almost confluent plaques 





Figure A.2 Representations of A) Genetic manipulations performed in BW25113 B) The phage 
Φ80 bacterial attachment site (attB) and phage attachment site (attP) with homology indicated in 
capital letters and core region marked by arrows C) Nucleotide sequences of attB mutants. The 
nucleotide sequence of the core region has been sufficiently changed while preserving the amino 






Figure A.3 Test of phage production and lysogeny. A) Phage titers were calculated by spotting 
10 µl of ten-fold dilutions of the relevant phage stocks on top agar containing exponentially 
growing cells of susceptible BW25113 at 30˚C. Clear zones denote confluent lysis whereas distinct 
plaques formed on the last two dilutions of the attB80 mutant strains. B) Lysogenic strains were 
tested by streaking a culture across a thick streak of a phage stock. Lysogens survive due to their 
inability to be superinfected whereas non-lysogens are killed by phage infection. C) PCR 
amplification across the bacterial attachment site to verify lack of phage lysogeny. The larger sizes 
of the bands in the mutant strains relative to the wild type band is due to insertion of the kanamycin 
resistance determinant.  
